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General Introduction 
Historical background-
All organisms must adapt to their environment in order to survive. To 
achieve good adaptation, communication between cells and organs is essential. 
The two main systems controlling this communication are the nervous system 
and the endocrine system. The nervous system consists of neurons and glia, 
and is specialized in the rapid transport of information over long distances in 
the form of action potentials along axons and release of neurochemical 
messenger molecules (neurotransmitters) from synapses that are in direct 
contact with their target (e.g. Kandel et ai, 1991). The endocrine system works 
slower, via the secretion of hormones into the blood that carries them to their 
target tissues (e.g. Eckert and Randall, 1983). The nervous and endocrine system 
strongly influence each other's activities. The major centre of neuroendocrine 
integration is the pituitary gland where both systems cooperate in the control 
of peripheral targets, e.g. in the regulation of development, growth, reproduction 
and adaptation. An interesting object to study the collaboration between the 
nervous and the endocrine system is the melanotrope cell in the South African 
clawed toad, Xenopus laevis. The melanotrope cell of the pars intermedia of the 
pituitary gland plays a pivotal role in the complex process of background 
adaptation. Secretory activity of this cell is controlled by a number of 
neurotransmitters and neuropeptides. 
Xenopus laevis and background adaptation 
Many amphibians, including the clawed toad Xenopus laevis, can modify 
the colour of their skin by altering the distribution of pigment in dermal 
pigment-containing cells (chromatophores). The black pigment melanin is 
stored within special granules, the melanosomes, that are contained within 
melanophores. In fully white background-adapted amphibians, these granules 
are aggregated around the nuclei of the melanophores, while in animals adapted 
to a black background the melanosomes are dispersed throughout the 
melanophore cytoplasm and, consequently, the skin shows a dark colouration 
(Waring, 1963; Bagnara and Hadley, 1973). 
The process of adaptation to changes in background light intensity by 
Xenopus can be considered as a neuroendocrine reflex in which photic stimuli 
control the secretion of a melanotropic factor, a-melanophore-stimulating 
hormone (ot-MSH), from the melanotrope cells (Fig. 1). In animals on a black 
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background this hormone stimulates the dispersion of melanin within the 
melanophores, giving the animal a dark skin. On a white background a-MSH 
is not released and consequently the pigment is concentrated in a perinuclear 
position and the animal appears white. 
Regulation of melanotrope cell secretory activity 
The neural signals initiated by light stimuli in the eyes are carried via 
the optic nerves to hypothalamic centres that regulate the activity of the 
melanotrope cells. This regulation involves both stimulatory and inhibitory 
neural factors. The effects of five of these hypothalamic factors and one 
extrahypothalamic factor have been shown by their actions on the release of 
a-MSH from the melanotropes, as assessed by in vitro superfusion studies with 
isolated pituitary neurointermediate lobes (consisting of the pituitary pars 
intermedia and pars nervosa). Thyrotropin-releasing hormone (TRH) and 
corticotropin-releasing hormone (CRH) stimulate the release of a-MSH 
(Verburg-van Kemenade et ah, 1987b,c). These factors are produced in the 
magnocellular nucleus of the hypothalamus and transported to the nerve 
terminals in the pars nervosa (Tuinhof et al., 1994). They probably reach the 
melanotropes in a diffuse, neurohormonal fashion (Jenks et al., 1993). Neurons 
projecting from the suprachiasmatic nucleus contain three coexisting neural 
factors (Tuinhof et al., 1994), namely neuropeptide Y (NPY), dopamine (DA) 
and γ-aminobutyric acid (GABA), all of which inhibit the release of a-MSH 
(Verburg-van Kemenade et al., 1986,1987a; Jenks et al., 1993). These factors are 
released from terminals which make synaptic contacts on the melanotropes in 
the pars intermedia (de Rijk et al, 1990b, 1992; van Strien et al, 1991). In addition, 
another area of the brain outside the hypothalamus, the locus coeruleus of the 
metencephalon, is involved in the inhibitory control of the melanotrope 
secretory activity, by the release of noradrenaline (Verburg-van Kemenade et 
ai, 1986; Tuinhof et ai, 1994). 
Biosynthetic processing in the melanotrope cell 
Biologically active peptides are usually synthesized as parts of large 
biologically inactive precursor proteins. The precursor protein undergoes a 
series of posttranslational events in order to yield the biologically active 
peptides that are enclosed within the precursor sequence. Processing of most 
12 
General Introduction 
Fig. 1 The neuroendocrine reflex regulating pigment dispersion in dermal 
melanophores of amphibians during the process of background adaptation. The visual 
input is centrally integrated, leading to activation or inactivation of neurons in the 
hypothalamus controlling the pituitary gland. Both inhibitory (DA, GABA and NPY) 
and stimulatory factors (CRH and TRH) released from the hypothalamic neurons are 
regulating the secretion of a-MSH from the melanotropes. In addition, neurons in the 
locus coeruleus of the metencephalon are involved in regulating a-MSH secretion by 
the release of NA. CRH = corticotropin-releasing hormone, DA = dopamine (D2 
receptor), GABA = γ-aminobutyric acid (GABAA and GABAg receptors), LC = locus 
coeruleus, MCN = magnocellular nucleus, NA • noradrenaline, NPY = neuropeptide 
Y (Y| receptor), pn = pars nervosa, pi = pars intermedia, SCN = suprachiasmatic 
nucleus, TRH = thyrotropin-releasing hormone. 
prohormones occurs at pairs of basic amino acids (classical processing sites) 
which flank the bioactive peptides on both sides (Douglass et al., 1984). Recently, 
a family of specific proteolytic enzymes responsible for such prohormone 
processing in the regulated secretory pathway have been elucidated and called 
the prohormone convertases (Halban and Irminger, 1994). Less frequently, 
proteolysis occurs at single basic amino acids. This processing is thought to 
follow certain sequence motifs around the monobasic cleavage site, called the 
consensus sequence (Devi, 1991). In general, cleavage occurs C-terminally to 
the basic amino acid(s) followed by removal of the basic amino acid(s) by 
carboxypeptidases (Mains et al, 1983; Mains and Eipper, 1984). The peptide 
13 
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products formed after cleavage of the precursor protein can be modified 
covalently by the addition of various chemical groups. Some of these 
modifications (such as acetylation, amidation, glycosylation and 
phosphorylation) can activate, inactivate or modify the activity of a peptide. 
Depending on the nature of the N-terminal amino acid residue a peptide can 
be N-terminally acetylated by N-acetyltransferase, which may either stimulate 
or inhibit the biological activity of the peptide (Creighton, 1993). The amidating 
enzyme (peptidylglycine a-amidating monooxygenase), which converts 
peptides that terminate in glycine to des-glycine peptide amide, is often 
important for biological activity and contributes to biological stability of the 
peptide (Bradbury and Smyth, 1991). Glycosylation is one of the most prevalent 
postranslational modifications, but has no well defined universal purpose. 
Potential glycosylation sites are the nitrogen atom of the asparagine residues 
(N-glycosylation) and the oxygen atom of the hydroxyl group of serine and 
threonine residues (O-glycosylation). Finally, phosphorylation (usually at 
serine, threonine or tyrosine residues) is one of the most frequently used 
modifications to reversibly regulate protein activity (Creighton, 1993). Tissue-
specific differential posttranslational processing mechanisms represent a 
strategy for generating discrete subsets of peptide end products from a common 
precursor. 
The pituitary proopiomelanocortin (POMC) biosynthetic pathway is one 
of the best understood examples of this strategy. The POMC precursor contains 
a number of potential biologically active peptide end products, such as a-MSH, 
ß-MSH and γ-MSH, all of which contain the so-called MSH core sequence (his-
phe-arg-trp), in addition to adrenocorticotropic hormone (ACTH), ß-lipotropic 
hormone (ß-LPH) and the ß-endorphin family of peptides (for review see Mains 
and Eipper, 1984). a-MSH is C-terminally amidated and both oc-MSH and 
ß-endorphin have been shown to undergo N-terminal acetylation (Dores et al., 
1988). This increases the melanotropic activity of a-MSH but eliminates the 
opiate activity of ß-endorphin. Furthermore, several peptide products with 
unknown function are produced, for instance acidic joining peptide (AJP) and 
the N-fragment. Processing of the POMC precursor to these end products is 
tissue-specific. Whereas in the corticotrope cells of the pituitary pars distalis 
POMC is processed to e.g. ACTH, ß-lipotropic hormone and N-glycosylated 
16 kDa N-terminal peptide, in the melanotropes processing of POMC gives 
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rise to smaller peptides such as α-MSH, corticotropin-like intermediate lobe 
peptide (CLIP) and endorphins (for review see Jenks et ai, 1988; Smith and 
Funder, 1988). 
POMC 
AJP _AÇTH 0-LPH_ 
f
 } =glyeosylation 
' i « ? " a ι ~ τ ' 
α-MSH CLIP N-lragmenl 0-MSH 
Jj-eiidorphins 
Fig. 2 Structure of Xenopus laevis POMC. The Xenopus POMC molecule, lacking the 
N-terminal signal sequence, is drawn to scale, along with various peptides expected 
to be produced as well as the dibasic amino acid cleavage sites. Abbreviations are 
explained in the text. 
The pars intermedia of the pituitary gland of Xenopus laevis is very 
suitable to study the functioning of neuroendocrine cells because it consists of 
an almost homogeneous population of melanotrope cells. The activity of these 
cells can easily be manipulated by altering the colour of the background. 
Changing the background from white to black results in an elevated release of 
α-MSH, accompanied by a higher rate of POMC gene transcription (Martens 
et al., 1987; Ayoubi, 1991). Furthermore, biosynthesis studies have revealed 
that over 90% of the products released by the melanotropes are derived from 
the POMC precursor. The entire genome of Xenopus laevis has been duplicated 
some 30 million years ago (Bisbee et al., 1977; Thiebaud and Fischberg, 1977) 
resulting in the appearance of two POMC genes (A and B) which are 
coordinately expressed (Martens, 1986; Martens et al., 1987; Deen et al., 1992). 
Apparently, these two genes have been highly conserved resulting in only minor 
(or no) differences in the peptide end products derived from the two 
prohormones. 
Many studies have focused on α-MSH release from melanotropes of 
Xenopus laevis (for review see Jenks et al, 1993). This peptide is a major secretory 
product and has been completely characterized through sequence analysis 
(Rouillé et al., 1989). A variety of other products released from the Xenopus 
melanotrope have been studied though never fully identified. These products 
are interesting as they may have important physiological functions. In this 
r,-MSH 
VMSH 
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respect the fundamental question raises whether all POMC end products are 
released simultaneously or whether the melanotrope cells release them in a 
differential, selective fashion. 
Aims and outline of this thesis 
The first aim of this thesis was to elucidate the nature of the POMC end 
products present in and released from the melanotrope cells of Xenopus laevis. 
Therefore, antisera specific for Xenopus POMC-derived peptides were obtained 
and used to isolate and identify these peptides. The second aim was to test the 
effects of neural classical messengers (neurotransmitters, neuropeptides) on 
the release of these peptides, paying particular attention to the possibility of 
differential regulation of peptide secretion. 
In Chapter 2 the C-terminal part of the POMC precursor is studied. The 
terminal product of processing of endorphins in the melanotrope cells of 
Xenopus laevis was purified and identified by fast-atom bombardment tandem 
mass spectrometry. This product was found to be an acetylated endorphin 
unique to Xenopus, namely a,N-acetyl-ß-endorphin[ 1-8], representing the major 
form of endorphin immunoreactivity in these cells. Chapter 3 goes into detail 
concerning the effect of environmental background changes on the activity of 
the acetylation process of both the a-MSH and the ß-endorphin-related 
peptides. These studies demonstrate that a-MSH and ß-endorphin are 
differentially acetylated. In Chapter 4 attention is given to the N-terminal part 
of the POMC precursor. The biosynthesis and release of the N-terminal and 
N-terminal-derived peptides is examined. Surprisingly, not only γ-MSH but 
also the larger γ-MSH-containing peptides were shown to be released. The 
γ-MSH peptides generated from the N-terminal of POMC have been isolated, 
and identified using electrospray mass spectrometry and amino acid sequencing 
by Edman degradation (Chapter 4). The recent introduction of matrix-assisted 
laser desorption/ionization mass spectrometry has, theoretically, made it 
possible to determine the complete peptide composition of a single cell. In 
Chapter 5 this technique was used on a single melanotrope cell and allowed 
the identification of individual POMC-derived peptides on the basis of their 
molecular weights. In Chapter 6 attention was focused on the regulation of 
16 
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secretion from the melanotrope cell. To examine the release of the complete set 
of POMC-derived peptides, the melanotrope cells were labelled using 
radioactive amino acids. The release of the radiolabelled peptides was studied 
in an in vitro superfusion system. From these secretory studies the presence of 
two different peptide compartments within the cell was demonstrated and, 
using neural messengers, evidence is obtained for differential regulation of 
the release of peptides from these compartments. Finally, chapter 7 concerns a 
new regulatory mechanism functioning within the pars intermedia, namely 
autoexcitation of melanotrope cells through the neurotransmitter acetylcholine. 
This study demonstrates that the melanotropes produce acetylcholine and that 
they contain a specific receptor for this neurotransmitter. Furthermore, the effect 
of acetylcholine was studied simultaneously on peptide release and on changes 
in intracellular free calcium ions. The results strengthen the hypothesis that 
intracellular calcium oscillations are the driving force for secretion of POMC-
derived peptides from melanotropes of Xenopus laevis. 
In Chapter 8 all results presented in this thesis have been summarized 
and discussed in the light of the aim of the research described in this thesis. 
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α,Ν-acetyl-ß-endorphin [1-8] is the terminal 
product of processing of endorphins in the 
melanotrope cells of Xenopus laevis, as 
demonstrated by FAB tandem mass 
spectrometry 
F.J.C, van Strien, B.G. Jenks, W. Heerma, С Versluis, 
H. Kawauchi and E.W. Roubos 
Biochetn. Biophys. Res. Commun. 191,262-268 (1993) 
Chapter 2 
Abstract 
The major N-terminal-acetylated endorphin of the pars intermedia of 
Xenopus laevis was purified and submitted to fast-atom bombardment tandem 
mass spectrometry. The collisionally induced dissociation MS/MS spectrum 
of the [M+H]+ ion revealed sufficient fragment ions to determine 
unambiguously the identity of the peptide as α,Ν-acetyl-ß-endorphin [1-8], 
the sequence of which was predicted on the basis of the nucleotide sequence of 
Xenopus POMC cDNA. The determination was confirmed by showing that the 
synthetic peptide of this structure had identical FAB tandem mass spectrometric 
characteristics as the endogenous endorphin. We conclude that α,Ν-acetyl-ß-
endorphin [1-8] is the terminal product of processing of endorphins in the 
melanotrope cell of Xenopus laevis. 
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Introduction 
Proopiomelanocortin (POMC) is a 35 kDa precursor protein that, in 
melanotrope cells of the pituitary gland, is processed to produce peptides such 
as α-melanophore-stimulating hormone (ct-MSH) and C-terminal-truncated 
forms of ß-endorphin (Eipper and Mains, 1980). In melanotrope cells of 
mammals both oc-MSH and the endorphins are N-terminally acetylated. The 
melanotropic activity of a-MSH is potentiated by this event while the opioid 
activity of the endorphins is lost (Eipper and Mains, 1980; Smyth et ah, 1979). 
The major tissue forms are a-MSH and acetylated endorphin [1-26], [1-27] and 
[1-31] (Zakarian and Smyth, 1982). It is generally accepted that the same 
acetyltransferase is responsible for the acetylation of both a-MSH and the 
endorphins (Glembotski, 1982). In the pars intermedia of the South African 
toad Xenopus laevis, however, acetylation of these peptides appears to be 
regulated differentially. Acetylation of a-MSH occurs just prior to or during 
the process of secretion and therefore the major tissue form of the peptide is 
desacetyl-a-MSH (Martens et al., 1981b; Dores and Rothenberg, 1987; Verburg-
van Kemenade et al, 1987c; Rouillé et al., 1989). For the endorphins, acetylation 
takes place intracellularly and the major tissue forms of the peptide are C-
terminally truncated, N-terminally acetylated endorphins (Dores and 
Rothenberg, 1987). While a-MSH has been structurally characterized in this 
amphibian species (Rouillé et al., 1989), conclusive identification of the 
endorphins is still lacking. Dores et al. (1991) have suggested that the major 
form of acetylated endorphin in melanotropes of X. laevis consists of 8 to 12 
amino acid residues from the N-terminal of ß-endorphin. More recently, on 
the basis of a coelution study with synthetic endorphins, Maruthainar et al. 
(1992) proposed that the major form is the 8 amino acid peptide. 
In this study the main acetylated endorphin end product in the pars 
intermedia of X. laevis has been purified and its sequence determined using 
fast-atom bombardment (FAB) tandem mass spectrometry. To confirm the 
deduced amino acid sequence, FAB tandem mass spectrometry was carried 
out with a peptide synthesized according to the putative structure of this 
endorphin as inferred from the cDNA structure of Xenopus POMC (Martens et 
al, 1985). 
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Methods 
Animals 
Adult Xenopus laevis with a weight of approximately 25 g were obtained 
from our laboratory stock. Toads were kept under constant illumination on 
either a black or a white background for at least 3 weeks (22°C). For the 
experiments, animals were decapitated and pituitary neurointermediate lobes 
were rapidly dissected. Lobes were homogenized in 1 ml 0.1 N ice-cold HCl 
and the extracts were freeze-dried under vacuum (Speed-Vac Concentrator 
Savant, New Brunswick Scientific, Watford, UK) or immediately submitted to 
reversed-phase HPLC. 
Reversed-phase HPLC 
A BioRad RSil C18 column (Richmond, CA, USA) was used with 0.5 M 
formic acid/0.14 M pyridine as the primary solvent and n-propanol as the 
secondary solvent: flow rate was 2 ml/min. One ml fractions were collected 
and dried under vacuum. Dried samples were resuspended in 0.02 M veronal 
acetate buffer containing 0.2 g/1 NaN3, 3 g/1 bovine serum albumin (Sigma, 
St.Louis, MO, USA) and 100 KIU/ml trypsin inhibitor (Serva, Heidelberg, 
Germany). As markers, standard human acetylated endorphins [1-16], [1-27] 
and [1-31] (Sigma) were submitted to reversed-phase HPLC. 
Radioimmunoassay 
The N-terminally acetylated endorphin antiserum was raised against 
salmon acetylated ß-endorphin, and is specific for the acetylated N-terminal 
of salmon ß-endorphin (Takahashi et al., 1984). The serum has full cross-
reactivity with the acetylated forms of mammalian ß-endorphin (Dores et al, 
1991). Cross-reactivity with nonacetylated forms of endorphin is less than 0.1 % 
(Dores et al, 1991). For radioimmunoassay the antiserum was used in a dilution 
of 1:250,000. Bound and free antibodies were separated by precipitation with 
15% polyethylene glycol and 2.4% ovalbumin as described previously (van 
Zoest et al, 1990). 
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Peptide purification 
Reversed-phase HPLC fractions containing the major immunoreactive 
product of lobes of animals adapted to a white background were dried and 
resubmitted to chromatography using the Smart system (Pharmacia LKB 
Biotechnology, Uppsala, Sweden). A C 2 /C 1 8 precision column (SC2.1 /10) was 
used with 0.0169% TEA in H 2 0 and acetonitrile as elution buffer. On-line 
detection was performed with a UV-monitor. Flow rate was 200 μΐ/min. 
Fractions of 30 sec were collected, dried and redissolved in buffer for 
radioimmunoassay, or in 10% acetic acid in methanol for FAB mass 
spectrometry. 
Fast-atom bombardment tandem mass spectrometry 
Fast-atom bombardment tandem mass spectrometry (FAB-MS/MS) was 
performed on a JEOL JMS SX/SX102A four sector instrument using 6 kV fast 
xenon atoms. Approximately 20 ng of peptide was placed on the probe tip in a 
glycerol matrix. Collisionally induced MS/MS spectra of the [M+H]+ ion were 
obtained by scanning the second mass spectrometer at a 50% main beam 
reduction using helium as a collision gas. 
Superfusion 
Neurointermediate lobes from black background-adapted Xenopus laevis 
were dissected and superfused using the microsuperfusion system described 
previously (van Zoest et al., 1990). Four 10 minute fractions were pooled and 
peptides were separated on reversed-phase HPLC. HPLC fractions were 
submitted to radioimmunoassay. 
Peptide synthesis 
N-terminal-acetylated endorphin [1-8] deduced from Xenopus laevis 
POMC cDNA (purity over 95%) was custom synthesized by the American 
Peptide Company (Santa Clara, CA, USA). 
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Results and Discussion 
The purpose of this study was to identify the terminal product(s) of 
processing of the endorphins in Xenopus melanotropes. HPLC-analysis coupled 
to a radioimmunoassay specific for acetylated endorphins revealed that 
neurointermediate lobe extracts of Xenopus possess at least six immunoreactive 
products (Fig. 1). 
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Fig. 1 Reversed-phase HPLC analysis of N-acetylated endorphin-immunoreactive 
material in extracts from neurointermediate lobes of white and black background-
adapted Xenopus laevis. Immunoreactive products are numbered from I to VI according 
to their retention time. Elution positions of synthetic human standard peptides 
(N-terminal-acetylated ß-endorphin [1-16], [1-27] and [1-31]) are indicated by arrows. 
The elution profile was similar to that found in mammals (Smyth, 1984; 
Autelitano et al., 1985; Facchinetti et ai, 1989) except for two peaks designated 
peak I and peak II (Fig. 1). An oxidation experiment with H 2 0 2 showed that 
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peak I represents the sulfoxide form of peak II. On the basis of elution positions 
of the standard acetylated ß-endorphins, peaks III, IV and V very likely 
represent the N-terminal-acetylated endorphins [1-16], [1-31] and [1-27], 
respectively. Likewise, based on the elution profiles found in rat 
neurointermediate lobes, peak VI probably is acetylated endorphin [1-26] 
(Smyth, 1984). The HPLC profiles of acetylated endorphins of 
neurointermediate lobes of white and black background-adapted Xenopus laevis 
displayed clear differences in the relative amounts of the various peptides. In 
the lobes of white background-adapted animals the majority of immunoreactive 
material was associated with peak I/II (77.2 ± 2.0%, n=3), while this same 
product represented only 44.5 ± 2.6% (n=3) in lobes of black background-
adapted animals. Apparently, under conditions of adaptation to a white 
background, the large endorphins (products III to VI) are processed to a small 
peptide represented in peak I/II. The observed accumulation of this peptide is 
in agreement with previous findings that melanotrope cells in white animals 
store peptides in the absence of secretion (Verbürg-van Kemenade et al., 1987c). 
Altogether our results permit the conclusion that the product present in peak 
I/II represents the terminal product of processing of the acetylated endorphins. 
The immunoreactive endorphin associated with peak II was further 
purified on the Smart system and studied with FAB tandem mass spectrometry. 
The FAB mass spectrum showed [M+H]+, [M+Na]+ and [M+K]+ ions at m/z 
943,965 and 981, respectively. The collisionally induced dissociation MS/MS 
spectrum of the [M+H]+ ion (Fig. 2A) revealed sufficient fragment ions to 
determine the amino acid sequence of the peptide unambiguously. This amino 
acid sequence is in exact agreement with that of the aminoterminal eight amino 
acid residues of ß-endorphin [1-31], including the acetylated amino group at 
the N-terminus. In this calculation the amino acids were deduced from the 
nucleotide sequence of X. laevis POMC cDNA (Martens et al., 1985). On the 
basis of this sequence, we had the acetylated ß-endorphin [1-8] of X. laevis 
synthesized. This synthetic peptide showed identical chromatographic 
characteristics as product II on reversed-phase HPLC (not shown) and gave an 
identical FAB tandem mass spectrum (Fig. 2B). 
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Fig. 2 Collision-induced dissociation spectra of the [M+H]+ ion from (A) product II 
and (B) 20 ng of synthetic Xenopus α,Ν-acetyl-ß-endorphin [1-8]. The most abundant 
sequence ions are indicated in the MS/MS spectrum of the synthetic peptide. 
Therefore, we conclude that this product is α,Ν-acetyl-ß-endorphin 
[1 -8]. This supports the proposal of Maruthainar et al. (1992) and it seems likely 
that our product is identical to the terminal product of processing detected by 
Dores et al. (1991 ). Analysis of the medium from superfused neurointermediate 
lobe tissue shows that α,Ν-acetyl-ß-endorphin [1-8] is a major release product 
(Fig. 3). Therefore, the product represents an important component of the 
secretory signal from melanotrope cells. 
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fraction number 
80 
Fig. 3 Reversed-phase HPLC analysis of N-terminal-acetylated endorphin-
immunoreactive material released from superfused neurointermediate lobes of X. iaevis. 
Elucidation of the amino acid sequence of precursor molecules has clearly 
underlined the importance of pairs of basic amino acid residues (lys-arg, arg-
arg, lys-lys) as potential recognition sites for specific proteases. I lowevcr, such 
dibasics are not the only cleavage sites. From the structure of Xenopus Iaevis 
POMC it is clear that production of α,Ν-acetyl-ß-endorphin [1-8] must involve 
cleavage at a single arginine residue at position 9 of ß-endorphin in this species. 
This observation draws attention to the evolutionary significance of single 
arginine residues as sites for the processing of opioid peptides. From the atrial 
gland of the mollusk Apiysia californica an enzyme has been isolated that 
proteolytically cleaves dynorphin at a single arginine residue (Wallace, 1984). 
This suggests that phylogenetically this type of opioid precursor cleavage is 
an old principle. Apparently, it is well conserved, because in mammals both 
dynorphin [1-8] and metorphamide are formed by cleavage at a single arginine 
residue (Minammo et al., 1980; Weber et al., 1982). As to processing of ß-
endorphin, cleavage at a single arginine residue has been shown once before, 
viz. in the dogfish (Lorenz et al., 1986). It is to be expected that this mode of 
processing is a general phenomenon in lower vertebrates because in all non-
mammalian vertebrates studied, POMC shows a single arginine residue in the 
N-terminal region of ß-endorphin (Kawauchi et ai, 1980; Naudé et al., 1980; 
Dores, 1983; Martens et al, 1985; Hilario et ai, 1990). 
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Abstract 
Immunocytochemical analysis revealed the presence of acetylated 
endorphins in both melanotropes and corticotropes of the pituitary gland of 
Xenopus laevis. Chemical acetylation studies to determine the steady state level 
of acetylated versus nonacetylated endorphins showed that virtually all 
endorphins are acetylated in both melanotropes and corticotropes. Apparently, 
Xenopus is unique among vertebrates as nonacetylated endorphins are major 
end products in the distal lobe of all other vertebrate species studied thus far. 
Dynamics of endorphin biosynthesis in melanotrope cells using pulse-chase 
analysis coupled to immunoaffinity chromatography revealed that processing 
of proopiomelanocortin to produce N-terminal-acetylated endorphins is very 
rapid. To determine the effect of long-term background adaptation on 
acetylation status of endorphins and oc-MSH-related peptides, Xenopus laevis 
were adapted for 3 or 6 weeks to either a black or a white background. In both 
physiological states the major intracellular form of a-MSH-related peptides in 
melanotropes was desacetyl-a-MSH while the major endorphin-related peptide 
was a,N-acetyl-ß-endorphin[l-8]. In the medium of superfused 
neurointermediate lobes of black background-adapted animals the major form 
of secreted melanotropins and endorphins was oc-MSH and α,Ν-acetyl-ß-
endorphin[l-8], respectively. We conclude that there is a marked spatio-
temporal difference in acetylation of melanotropin and endorphins, with rapid 
intracellular acetylation of endorphins while melanotropin is acetylated at the 
time of its exocytosis. In the medium of superfused neurointermediate lobes 
of white background-adapted animals the amount of desacetyl-a-MSH was 
much higher than in the medium of lobes of black-adapted animals. Therefore, 
the secretory signals from melanotrope cells of black- and white-adapted 
Xenopus appear to differ with respect to the degree of acetylation of the 
melanotropins. This difference may underlie the strategy of Xenopus to regulate 
dermal melanophore activity during physiological background adaptations. 
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Introduction 
N-terminal acetylations are important in determining the biological 
activity of several peptide hormones and neuropeptides (Tsunasawa and 
Sakiyama, 1984). Of particular interest in this regard is acetylation of ct-MSH-
related and ß-endorphin-related peptides. Both types of peptide come from a 
common precursor protein, proopiomelanocortin (Eipper and Mains, 1980). 
The N-terminal acetylation of desacetyl-ct-MSH to form a-MSH increases the 
melanotropic activity of the peptide 10-fold (Rudman et al, 1983) whereas 
N-terminal acetylation completely eliminates the opiate activity of endorphins 
(Deakin et al, 1980). In general, nonacetylated forms of endorphins and 
melanotropins (e.g. desacetyl-a-MSH) are found in neurons of the central 
nervous system, whereas the same peptides occur in their acetylated form in 
the pituitary intermediate lobe. The coexistence of acetylated endorphins and 
a-MSH within intermediate lobe melanotrope cells of mammals has led to the 
idea that the peptides are acetylated by the same enzyme (Glembotski, 1982; 
Dores and Rothenberg, 1987). An interesting case with respect to the acetylation 
of melanotropin concerns several amphibian species, where the major 
intracellular form is desacetyl-a-MSH and the acetylation reaction to form a-
MSH is associated with the secretory process (Martens et al, 1981; Vaudry et 
al, 1983; Verburg-van Kemenade et al, 1987c; Rouillé et al, 1989; Dores et al, 
1991; Jenks et al, 1993). Until recently, little was known about the endorphins 
in amphibian melanotrope cells. It has been shown that a small, N-terminal 
acetylated peptide, a,N-acetyl-ß-endorphin[l-8], is the major intracellular form 
of ß-endorphin-related peptides in the melanotrope cells of Xenopus laevis (Dores 
et al, 1991; Maruthainar et al, 1992; van Strien et al, 1993). The melanotrope 
cells of this species have been shown to be intimately involved in background 
adaptation, with melanotropes of white background-adapted animals being 
small and biosynthetically inactive whereas black-adapted animals possess 
large, biosynthetically active cells (Hopkins, 1970; de Rijk et al, 1990b). The 
purpose of the present study was to gain a better insight into spatiotemporal 
aspects of the acetylation of melanotropins and endorphins in Xenopus 
melanotrope cells in relation to physiological background adaptations. In 
particular, the present studies examine: 
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[1] the distribution of acetylated endorphins in the pituitary gland, by 
immunocytochemistry, 
[2] the dynamics of endorphin biosynthesis and acetylation in melanotrope 
cells of black background-adapted Xenopus, using pulse chase analysis, 
[3] the steady-state levels of acetylated and nonacetylated endorphins in 
these cells in white and black-adapted animals, by conducting chemical 
acetylation studies, 
[4] the effects of long-term (up to 6 weeks) adaptations to white and black 
backgrounds on the acetylation status of melanotropins and endorphins in the 
melanotropes, and 
[5] the effects of such adaptations on the secretory signal of the melanotropes, 
with respect to melanotropins and endorphins. 
Materials and Methods 
Animals 
Adult Xenopus laevis with a weight of approximately 25 g were obtained 
from our laboratory stock. Toads were kept under constant illumination on 
either a black or a white background for at least 3 weeks (22°C) and fed trout 
pellets (Trouvit, Trouw, Putten, The Netherlands) once a week. 
Immunocytochemistry 
Brains and pituitary glands were fixed in Bouin's fluid. Sagittal sections 
(25 μτή) were immunostained with the peroxidase-anti-peroxidase method, 
according to de Rijk et al. (1990b), using a Xenopus α,Ν-acetyl-ß-endorphin 
[1-8] antiserum (1:10,000). This serum was produced in our laboratory by 
immunization of rabbits with a,N-acetyl-ß-endorphin[l-8] coupled to 
thyroglobulin with carbodiimide. The specificity of the antiserum was shown 
by radioimmunoassay. Cross-reactivity with a-MSH, ACTH and synthetic 
γ-MSH was less than 0.1%. The antiserum has full cross-reactivity with the 
acetylated forms of mammalian ß-endorphin, but cross-reactivity with 
nonacetylated forms of endorphin is less than 0.1 %. Serum specificity was tested 
immunohistochemically, as follows: (1) replacement of the antiserum by normal 
rabbit serum, (2) omission of the antiserum, (3) preadsorption of the antiserum 
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with: a,N-acetyl-ß-endorphin[l-8] and [1-27], ß-endorphin[l-8] and [1-27], or 
α-MSH (Sigma, St. Louis, MO, USA). Immunostaining was fully abolished in 
tests (1) and (2). Preadsorption of the ß-endorphin antiserum with acetylated-
ß-endorphins completely abolished the immune reaction; no change in 
immunostaining occurred after preadsorption with any of the other peptides. 
Chemical acetylation 
Neurointermediate and distal pituitary lobes of Xenopus laevis or the 
mouse were homogenized in 1 ml 0.1 N ice-cold HCl, and the extracts were 
freeze-dried under vacuum (Speed-Vac Concentrator Savant, New Brunswick 
Scientific, Edison, UK) and subsequently submitted to reversed-phase HPLC. 
Each HPLC fraction was divided into two samples and dried. One sample was 
submitted directly to radioimmunoassay for acetylated endorphins. The other 
sample was redissolved in 100 μΐ of sodium phosphate (50 mM; pH 8.0) and 
acetylation was started by adding 2 μΐ of acetic anhydride (Sigma) to the sample, 
followed by vigorous stirring. The sample was then dried and redissolved in 
veronal acetate buffer (pH 8.6) and also assayed for acetylated endorphins. 
Pulse-chase studies 
For biosynthesis experiments, X. laevis adapted for 3 weeks to a black 
background were decapitated and neurointermediate lobes were rapidly 
dissected. The lobes were pulse-incubated in 100 μΐ Xenopus Ringer's solution 
(Martens et al., 1980) containing 100 цСі [ H]threonine (Amersham, 
Buckinghamshire, UK), for 1 h. Lobes were then chase-incubated for 30 min or 
6 h, washed 3 times in Ringer's solution, and homogenized in 1 ml 0.1 N HCl. 
Lobe extracts were dried and redissolved in Tris buffer (0.1 M Tris, 0.5 M NaCl; 
pH 8.0) and submitted to immunoaffinity chromatography, to specifically 
separate radioactive ß-endorphin-related peptides from other radiolabelled 
peptides. To prepare the immunoaffinity column 1 g CNBr-activated Sepharose 
4B (Pharmacia, Uppsala, Sweden) was swelled in 0.001 N HCl and antibodies 
were coupled to the gel using 80 μΐ of pure a,N-acetyl-ß-endorphin[l-8] 
antiserum, for 16 h at 4°C. For chromatography, Tris buffer was used as starting 
buffer and urea (7 M) as elution buffer to remove immunoreactive peptides. 
Flow rate was 0.5 ml/min and 2 min fractions were collected. The eluted 
radioactive peptides were submitted to HPLC and radioactivity in each HPLC 
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fraction was determined using a ß-counter. 
Analysis of immunoreactive peptides 
For analysis of neurointermediate lobe content, freshly dissected lobes 
from animals adapted for 3 or 6 weeks to a white or a black background were 
immediately extracted and submitted to HPLC, and fractions were assayed 
for a-MSH and acetylated ß-endorphin-related peptides. For analysis of 
secretory products, lobes were dissected, rinsed in Ringer's solution and 
superfused using the microsuperfusion system described previously (van Zoest 
et al, 1990). The first seven 10 min fractions were pooled and peptides were 
separated on reversed-phase HPLC. HPLC fractions were submitted to 
radioimmunoassay. 
Reversed-phase HPLC 
A BioRad C^8 column was used with 0.5 M formic acid/0.14 M pyridine 
buffer as the primary solvent and n-propanol as the secondary solvent; flow 
rate was 2 ml/min. Dried samples were redissolved in pyridine buffer and 
applied to the HPLC column. One minute fractions were collected and dried 
under vacuum. Dried fractions were resuspended in 0.02 M veronal acetate 
buffer (pH 8.6) containing 0.02% NaN3 , 3 % bovine serum albumin (Sigma) 
and 100 μΐ/ΐ trypsin inhibitor (Trasylol; Sigma). Synthetic Xenopus α,Ν-acetyl-
ß-endorphin[l-8] and human acetylated endorphins [1-16], [1-27], [1-31] and 
a-MSH (Sigma) were submitted to reversed-phase HPLC separately, as marker 
peptides. 
Radioimmunoassay 
Acetylated endorphin immunoreactivity was measured using the X. 
laevis α,Ν-acetyl-ß-endorphin antiserum (final dilution 1:10,000); methods used 
have been described previously (van Zoest et al, 1989). The concentrations of 
a-MSH were measured using an anti-a-MSH serum (final dilution 1:60,000) 
produced and characterized in our laboratory (van Zoest et al., 1989). Final 
dilution of the antiserum was 1:60,000. Bound and free antibodies were 
separated by precipitation with polyethylene glycol and ovalbumin (15% and 
2.4%, respectively). 
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Results 
Immunocytochemical localization and chemical analysis of ß-endorphin-related peptides 
Immunocytochemical analysis of the pituitary of Xenopus laevis using 
anti a,N-acetyl-ß-endorphin[l-8] showed strong acetylated endorphin-like 
immunoreactivity not only in the melanotrope cells of the pars intermedia but 
also in the corticotrope cells of the pars distalis (Fig. 1). No immune staining 
was observed in the neural lobe of the pituitary or in the brain. 
• . • : . • . •· •• ... ... 
Fig. 1 Immunocytochemical demonstration of acetylated ß-endorphin-related peptides 
in the X. laevis pituitary gland. Saggital section (25 μιη) stained with the peroxidase-
anti-peroxidase method and anti α,Ν-acetyl-ß-endorphin. H=hypothalamus, 
ME=median eminence, PD=pars distalis, PI=pars intermedia, PN=pars nervosa. 
Bar=100 μιη. 
The immunoreactive material in the corticotropes was studied by 
chemical analysis of the pars distalis. Reversed-phase HPLC in combination 
with radioimmunoassay for acetylated endorphins revealed one single 
immunoreactive product, eluting at the same position as α,Ν-acetyl-ß-
endorphin[l-8] (Fig. 2A). Chemical acetylation of the endorphins in the pars 
distalis did not result into any additional endorphin-like product (Fig. 2B), 
indicating the exclusive presence of acetylated endorphins. To demonstrate 
the effectiveness of the methodology to reveal nonacetylated endorphins, mouse 
pituitary pars distalis extracts were submitted to radioimmunoassay for 
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Analysis of N'-acetylated-ß-endorphin-immunoreactive peptides within and secreted 
from neurointermediate lobes 
When peptides from lobes of either black- or white-adapted toads were 
chromatographed on reversed-phase HPLC, the major immunoreactive 
endorphin emerged with a retention time of 14.5 min, representing α,Ν-acetyl-
ß-endorphin[ l -8] (Fig. 4A,C,E). This p roduc t was also the major 
immunoreactive endorphin present in the incubation medium (Fig. 4B,D,F). A 
second peak eluted just before a,N-acetyl-ß-endorphin[l-8] and represents the 
sulfoxide form of the latter product. A third peak in the profiles, eluting at 18.5 
min, represents another small acetylated endorphin, probably acetylated 
endorphin 1-16 or 1-17. No differences were found between the HPLC profiles 
of lobes or incubation medium of Xenopus adapted to a white background for 
37 
Chapter 3 
different periods (Fig. 4C-F). In contrast, the HPLC profile of lobes of black-
adapted Xenopus revealed a number of large products in addition to the small 
products mentioned above (Fig. 4A). 
(0 
о 
;> 
о 
(0 
e-o 
T 3 
φ 
я 
2? 
0) 
υ 
я 
18-
15 
lobe 
37% 
\ 
15 20 25 3D 35 40 
О 
с 3 
F F 
9) 
JÉ 
С 
SI 
30 
25 
20 
15-
10 
lobe 
84% 
AJ,W 
medium 
61% 
501 I medium I 
401 
30 
85% 
B 
15 20 25 30 35 40 
5 10 15 20 25 30 35 40 5 10 15 20 25 30 35 40 
40 ι 
35· lobe 
30-
82% 
T ^ ~ i -
medium 
30-) 
W 
81% 
\ 
0 i , л/. ^ 5 10 15 20 25 30 35 40 5 10 15 20 25 30 35 40 
HPLC elution time (min) 
Fig. 4 HPLC analysis of acetylated-endorphins within neurointermediate lobes or 
released from lobes in vitro of X. ¡aevis adapted to a black background for 3 weeks 
(A=lobe, B=incubation medium), to a white background for 3 weeks (C=lobe, 
D=incubation medium), or to a white background for 6 weeks (E=lobe, F=incubation 
medium). The amount of a,N-acetyl-ß-endorphin[l-8] together with the sulfoxide form 
is indicated as percentage of total immunoreactivity (eluting at 14.5 and 10.5 min, 
respectively). 
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These large products, probably representing the 26, 27 and 31 residue forms 
of acetylated ß-endorphin, reflected over 50% of the total immunoreactivity 
and were only found in neurointermediate lobe tissue extracts and not in the 
incubation medium (Fig. 4B). The only difference between the secretory signal 
of lobes of black-adapted compared to that of white-adapted Xenopus laevis 
was the increased amount of the acetylated endorphin product eluting at 18.5 
min in black-adapted animals. 
Chemical acetylation of the peptides of the pituitary intermediate lobe 
did not show the appearance of any new immunoreactive endorphins (data 
not shown), thus demonstrating the complete absence of nonacetylated 
endorphins in the melanotropes. 
Analysis of a-MSH-immunoreactive peptides within and secreted from 
neurointermediate lobes 
The major immunoreactive product in neurointermediate lobes of long-
term black and white-adapted Xenopus laevis was the desacetyl form of oe-MSH, 
eluting at 13 min (Fig. 5A,C,E). Together with the sulfoxide form (eluting at 
10.5 minutes) desacetyl-oc-MSH represented over 80% of total immunoreactivity. 
a-MSH (eluting at 16.5 minutes) was the dominant form of melanotropin in 
the medium of incubated lobes of both the black-adapted and the white-adapted 
animals, but there were differences in the relative amounts of the acetylated 
and nonacetylated melanotropins between the two groups (Fig. 5B,D,F). 
The HPLC profile of the released melanotropin-immunoreactive material 
of black-adapted animals showed almost exclusively a-MSH (Fig. 4B), whereas 
animals adapted for 3 or 6 weeks to a white background had released almost 
equal amounts of desacetyl-a-MSH and a-MSH. In the secretory signal the 
unidentified a-MSH-immunoreactive products eluting before the sulfoxide 
formprobably represent fragments of a-MSH. 
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Fig. 5 HPLC analysis of α-MSH-related peptides within neurointermediate lobes and 
released from lobes in vitro of Xenopus laevis adapted to a black background for 3 
weeks (A=lobe, B=incubation medium), to a white background for 3 weeks (C=lobe, 
D=incubation medium), or to a white background for 6 weeks (E=lobe, F=incubation 
medium). The amount of desacetyl-a-MSH (13 min peak) and the sulfoxide form (10.5 
min peak) are indicated as percentages of total immunoreactivity in the lobe profiles 
(A,C,E). The amount of a-MSH (16.5 min peak) is indicated as percentage of total 
immunoreactivity in the medium (B,D,F). The vertical arrow indicates the elution 
position of a-MSH. 
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Discussion 
Xenopus corticotropes acetylate ß-endorphin-related peptides 
The immunocytochemical study indicates the presence of acetylated 
endorphins in corticotrope cells of X. laevis, which is in agreement with a 
previous report by Dores et al. (1991). This finding is extended by the chemical 
acetylation studies, which not only confirm the presence of acetylated 
endorphins but also show that Xenopus corticotropes, in contrast to mouse 
corticotropes, do not contain detectable amounts of nonacetylated endorphins. 
The fact that in Xenopus corticotropes endorphins are acetylated is surprising 
because in every mammalian species studied until now, corticotropes contain 
exclusively nonacetylated forms of ß-endorphin (Smyth et al., 1979; Ham and 
Smyth, 1984; Millington et al, 1992). Our HPLC analysis shows that in Xenopus 
corticotropes ß-endorphin is posttranslationally processed to a single 
α,Ν-acetylated and C-terminally shortened end product with elution 
characteristics of oc,N-acetyl-ß-endorphin[l-8], a peptide recently purified from 
the Xenopus pars intermedia and fully characterized (Dores et ai, 1991; 
Maruthainar et al, 1992; van Strien et al, 1993a). 
Xenopus melanotropes form a,N-acetyl-ß-endorphin[l-8] 
The chemical acetylation studies demonstrate the lack of nonacetylated 
endorphins in the neurointermediate lobe of X. laevis and, therefore, it can be 
concluded that not only the corticotropes (see above) but also the melanotrope 
cells in the Xenopus pars intermedia acetylate all their endorphins. In 
melanotrope cells of mammals acetylation of endorphins is a common feature 
(Mains and Eipper, 1981; Dores, 1988) and about 90% of the synthesized 
endorphins are N-acetylated (Zakarian and Smyth, 1982). The occurrence of 
ct,N-acetyl-ß-endorphin[l-8] in Xenopus melanotropes (Dores et al, 1991; 
Maruthainar et al, 1992; van Strien et al, 1993a) forms an interesting species 
difference, because in mammalian melanotropes ß-endorphins occur mainly 
as 26, 27 and 31 residue forms and a,N-acetyl-ß-endorphin[l-8] has not been 
found. The physiological function of this small endorphin is unknown. 
Melanotrope cells can produce different endorphin signals 
The present study shows that the HPLC profiles of neurointermediate 
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lobes clearly differ with respect to acetylated endorphins when animals adapted 
to different backgrounds are considered. While lobes of white-adapted animals 
contain mainly the small α,Ν-acetylated ß-endorphinfl-8], black-adapted toads 
display additional peptides that probably represent large, intermediate 
precursor forms of endorphin. This idea is confirmed by the biosynthesis studies 
of lobes of black-adapted animals, which reveal radiolabelled peptides with 
similar elution positions as large immunoreactive endorphins. The conclusion 
that cc,N-acetyl-ß-endorphin[l-8] is the final processing product is substantiated 
by the observation that this is the main peptide secreted into the superfusion 
medium from lobes of black-adapted animals. 
Melanotrope cells can produce different melanotropin signals 
Concerning the forms of melanotropins in the Xenopus pars intermedia, 
our experiments are in agreement with earlier studies (Martens et al., 1981; 
Verburg-van Kemenade et ai, 1987c; Dores et al., 1991; Maruthainar et ai, 1992) 
that in black-adapted animals the main tissue form of melanotropin is the 
nonacetylated peptide, i.e. desacetyl oc-MSH. However, in contrast to 
Maruthainar et al. (1992), who reported that after 6 weeks of adaptation to a 
white background intracellular melanotropins occur mainly in the acetylated 
form, we find that such a long-term adaptation does not affect the HPLC profile 
of melanotropins and that desacetyl-a-MSH remains the principal melanotropin 
within the pars intermedia. Apparently, changing the background colour 
condition does not influence the profile of intracellular melanotropins. 
However, a clear effect of adaptation was noted in the profile of secreted 
melanotropins. The superfusate of neurointermediate lobes of black-adapted 
Xenopus contained a high amount of acetylated melanotropin, namely of 
a-MSH, whereas in the superfusate of white-adapted animals relatively high 
amounts of desacetyl-a-MSH were found. Apparently, melanotropes of white-
adapted animals have a low capacity to acetylate melanotropins, which may 
be due to a low amount or a low activity of acetylation enzyme. 
Spatio-temporal difference in acetylation of melanotropin and endorphins 
The melanotropin and ß-endorphin-related peptides differ intracellularly 
in that the oc-MSH-related peptides occur nearly exclusively in the nonacetylated 
form whereas all ß-endorphin-related peptides are N-acetylated. This difference 
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indicates that in the Xenopus melanotrope cell endorphins are rapidly acetylated 
upon their formation while the acetylation of desacetyl-a-MSH takes place 
only at the time of exocytosis (Martens et al, 1981b; Verburg-van Kemenade et 
al, 1987c; Rouillé et al, 1989; Dores et al, 1991; Jenks et al, 1993). This spatio-
temporal difference in acetylation of the two peptides suggests that there are 
separate acetylation enzymes for endorphins and melanotropins. 
Physiological relevance of the release of melanotropins 
In Xenopus on a black background, the melanotropes are extremely active 
in synthesizing and releasing high amounts of oc-MSH (Wilson and Morgan, 
1979). The present results showing the high acetylation activity of such cells 
underline the importance of the melanotrope cell and of a-MSH in maintaining 
melanin dispersion in dermal melanophores in the long-term. On the other 
hand, it seems questionable whether melanotropins play an important role in 
the initial period of the adaptation process of white-adapted animals to a black 
background (first few days), because melanotrope cells of white-adapted 
animals have an extremely low biosynthetic activity (Hopkins, 1970; Jenks et 
al, 1977; de Rijk et al, 1990b) and hardly store any melanotropin (Martens et 
al, 1987; Dores et al, 1994). Possibly, it is for this reason that the melanophores 
are also controlled by the fast-acting autonomic (nor)adrenergic nervous system 
that stimulates melanin dispersion during the initial adaptation phase (van 
Zoest et al, 1989). 
It is interesting to compare the combined neural (adrenergic) and 
hormonal control of Xenopus melanophores with the control of background 
adaptation in another lower vertebrate, the lizard Anolis carolinensis. 
Remarkably, Anolis does not possess a neural control mechanism of its dermal 
melanophores (Kleinholz, 1938) but nonetheless is able to make very rapid 
changes in the degree of dispersion of pigment in melanophores. Anolis 
regulates melanin dispersion by secreting desacetyl-a-MSH (Larsson et al, 1979; 
Dores et al, 1994), the least potent form of melanotropin (Rudman et al, 1983). 
Among various lower vertebrates studied, Anolis has been found to store the 
highest amount of melanotropin within its pars intermedia (and Xenopus the 
lowest; Dores et al, 1994). This enables Anolis, in spite of the relatively low 
biological activity of desacetyl-a-MSH, to maintain its melanophores in the 
dispersed state, by releasing the peptide in high amounts for prolonged periods. 
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Use of desacetyl-a-MSH as the melanotropin has the advantage that by 
inhibiting secretion of this short-living peptide the animal can make fast 
adaptations to a light background. Thus, Xenopus and Anolis use different 
strategies to adapt in a flexible way to changed environmental light conditions. 
Whereas Xenopus uses (nor)adrenaline to adapt rapidly to a black background 
and a-MSH to maintain this adaptation in the long-term, Anolis controls both 
short- and long-lasting adaptations by only one factor, desacetyl-a-MSH. 
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Abstract 
The aim of this study was to determine the terminal products of 
processing of the N-terminal part of proopiomelanocortin (POMO in pituitary 
melanotrope cells of Xenopus laevis. Biosynthetic in vitro labelling studies 
showed that POMC is rapidly processed to form N-terminal peptides with an 
estimated molecular mass of 18 kDa, 9 kDa and 4 kDa. All peptides were 
released into the medium, indicating that they are processing end products. 
An antiserum was raised against the synthetic N-terminal eight amino acids 
of the putative Xenopus γ-MSH which is present in the N-terminal part of POMC. 
With immunocytochemistry we demonstrated that γ-MSH-immunoreactive 
material in the pituitary gland is restricted to the pars intermedia. A 
radioimmunoassay in combination with reversed-phase HPLC revealed the 
presence of at least two γ-MSH-like peptides. Complete purification followed 
by electrospray ionization mass spectrometry and amino acid sequence 
determination showed that these peptides are y^MSH and glycosylated 
y3-MSH. The amounts of these γ-MSH peptides were low compared to the other 
POMC-derived peptides, oc-MSH and ß-endorphin. Only about 10% of POMC 
is processed into γ-MSH peptides and the 4 kDa peptide, leaving the 18 kDa 
and 9 kDa peptides as the major end products. 
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Introduction 
The multifunctional precursor protein proopiomelanocortin (POMC) is 
produced in the melanotrope cells of the intermediate pituitary gland, in the 
corticotrope cells of the anterior pituitary gland and in various neurons in the 
brain (Jenks et ai, 1988; Smith and Funder, 1988). POMC is structurally very 
complex, comprising a collection of putative hormones and neurotransmitters. 
POMC-processing yields a number of pept ides , such as ACTH, the 
melanotropins and the endorphins, which have different biological functions. 
In melanotrope cells the major end products are melanotropins and endorphins. 
Elucidation of the POMC gene has revealed that the N-terminal cryptic region 
of POMC shares the sequence his-phe-arg-trp with a-melanotropin (cc-MSH, 
a-melanophore stimulating hormone) and ß-melanotropin (ß-MSH) (Nakanishi 
et ai, 1979). The putative peptide derived from this region was designated γ-
melanotropin (γ-MSH) and was expected to be a dodecapeptide on the basis of 
the location of dibasic amino acid residues in the precursor (Ling et al., 1979). 
However, although purification of γ-MSH peptides from bovine, porcine and 
human pituitaries showed the presence of the 12 amino acid residues long, C-
terminally-amidated lys^y^MSH ty-MSH), a second peptide was found, 
namely the N-glycosylated lys^g-MSH (y3-MSH). This peptide is Yj-MSH 
extended with the next 15 amino acids at its carboxyterminal site (Tanaka et al., 
1980; Bennett, 1986; Fenger, 1988). This finding is in contrast to the situation in 
the mouse and rat pituitary, where only y3-MSH is formed due to the fact that 
the C-terminal of γ^-MSH lacks an arginine cleavage site (Browne et al., 1981; 
Kawai et ai, 1984). In addition to γ-j-MSH, the porcine pituitary contains a 
glycine-extended y1-MSH molecule named y2-MSH (Fenger, 1988). 
The melanotrope cell of the amphibian Xenopus laevis is an example of a 
dynamic POMC-producing cell. The activity of the melanotropes in the pars 
intermedia can be manipulated by changing the colour of the background; 
melanotrope cells of black background-adapted animals are highly active in 
synthesizing and secreting melanotropins, whereas in white-adapted animals 
they are inactive and store secretory products (Weatherhead et al., 1971; 
Hopkins, 1972; Loh and Gainer, 1977; de Rijk et al, 1990). The N-terminal part 
of Xenopus POMC shows a sequence (amino acid residues 74-103) that is highly 
homologous (63%) with mammalian γ-MSH and possesses potential cleavage 
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sites at position 74-75 (the N-terminal start of mammalian γ-MSH), 88-89 and 
102-103 (Martens et ai, 1982). Therefore, it would seem likely that Xenopus 
POMC is enzymatically processed in the melanotrope cells to yield one or more 
γ-MSH peptides. In addition, such processing could generate several other 
cleavage products such as a 4 kDa N-terminal fragment and a connecting 
peptide. The aim of the present study was to investigate the direction of 
processing of the N-terminal POMC region and to identify the various end 
products, with particular attention to γ-MSH peptides. 
On the basis of the predicted amino acid sequence of Xenopus POMC 
(Martens, 1986) we produced an antiserum against the putative γ-MSH and 
deve loped a r a d i o i m m u n o a s s a y to localize and identify γ-MSH-
immunoreact iv i ty in the pituitary. Using this ant i serum different 
immunoreactive peptides were isolated, and subsequently their molecular 
weights and sequences were determined with electrospray ionization mass 
spectrometry and amino acid sequencing. Possible differences in γ-MSH 
contents between active and inactive melanotropes (black and white 
background-adapted animals, respectively) were examined and biosynthetic 
studies were conducted to follow synthesis of γ-MSH-related peptides in the 
melanotrope cells. Also, the distribution of γ-MSH-like peptides in the pituitary 
of Xenopus was established immunocytochemically. 
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Materials and Methods 
Animals 
Fifty adult Xenopus laevis with a weight of approximately 35 g were 
obtained from our laboratory stock. Toads were kept under constant 
illumination on a black or a white background, for at least 3 weeks at 22°C. 
They were fed trout pellets (Trouvit, Trouw, Putten, The Netherlands) once a 
week. 
Biosynthesis 
For biosynthetic experiments, black background-adapted animals were 
decapitated and pituitary neurointermediate lobes were rapidly dissected. 
Lobes were separately pulse-incubated in 100 μΐ Xenopus Ringer's solution (for 
composition see Martens et al., 1980) containing 100 μ Ο [35S]cysteine, 
[3H]glucosamine or [3H]threonine (Amersham, Buckinghamshire, UK), for 
1 h. Then they were chase-incubated for 8 h, washed 3 times in incubation 
medium, and homogenized in 1 ml 0.1 N HCl. Two lobes were preincubated 
for 4 h with 10 μg/ml tunicamycin (Sigma, St. Louis, MO, USA) and 
subsequently labelled with [35S]cysteine in the presence of tunicamycin 
(10 μg/ml). Lobe extracts and purified incubation media were either submitted 
to electrophoresis or to reversed-phase HPLC. 
Electrophoresis 
SDS ureum electrophoresis was carried out as described by Swank and 
Munkres (1971). Separation was performed with a stacking gel of 4.5% 
acrylamide and a 12.5% acrylamide separating gel. Samples were solubilized 
in 0.01 N H3P04/Tris (pH 6.8), 8 M urea containing 20% (v/v) glycerol, 1% 
(w/v) SDS, 1% ß-mercaptoethanol and 0.02% bromophenol blue, and heated 
at 100°C, for 3 min. 
Reversed-phase high performance liquid chromatography 
Neurointermediate lobes were homogenized in 1 ml 0.1 N ice-cold HCl 
and submitted to reversed-phase HPLC or used for radioimmunoassay. A C18 
HPLC column (RSil C18 HL column, BioRad, Hercules, CA, USA) was used 
with 0.5 M formic acid/0.14 M pyridine as the primary solvent and n-propanol 
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as the secondary solvent. Row rate was 2 ml /min. One min fractions were 
collected and dried u n d e r vacuum (Speed-Vac Concentrator, Savant 
Instruments, Farmingdale, NY, USA). Dried samples were resuspended in 
veronal acetate buffer for radioimmunoassay or submitted to a second reversed-
phase HPLC for further purification. Final purification was performed using a 
C 2 / C 1 8 HPLC column ^ R P C C 2 / C 1 8 SC 2.1/10, Pharmacia, Uppsala, Sweden) 
with 0.1% trifluoroacetic acid (TFA; Merck, Darmstadt, Germany) as starting 
buffer and 80% acetonitrile containing 0.1 % TFA as elution buffer, and controlled 
using direct UV detection. 
Superfusion 
Neurointermediate lobes from black background-adapted Xenopus laevis 
were dissected and superfused using the microsuperfusion system described 
previously (van Zoest et al., 1990). Four 10 min fractions were pooled and 
peptides were separated on reversed-phase HPLC. HPLC fractions were 
submitted to radioimmunoassay. 
Antiserum 
Αγ-MSH antiserum was raised in rabbits following Hong et al. (1983). A 
peptide comprising the eight N-terminal amino acid residues of the predicted 
γ-MSH peptide was synthesized (American Peptide Company, Santa Clara, 
CA, USA) and coupled to thyroglobulin (Sigma) by carbodiimide (Sigma). For 
immunization, the conjugated peptide was redissolved in 1 ml of saline and 
mixed with 1 ml of complete Freund's adjuvant (Sigma). The immune response 
was boosted every 4 weeks using incomplete Freund's adjuvant (Sigma). 
Preimmune serum was drawn before the first immunization. Starting nine 
weeks after the first immunization, 25 ml of blood were drawn every four 
weeks. The serum was stored at -20°C after addition of an equal volume of 
glycerol. The specificity of the antiserum was determined by radioimmunoassay 
which had a detection limit of 2.5 picogram for the synthetic γ-MSH peptide. 
The antiserum did not show cross reactivity with any of the other POMC-
related peptides tested (y2-MSH, a-MSH, ACTH), even when quantities as large 
as 10 ng were added. The absence of crossreactivity with a-MSH and ACTH is 
of significance because these peptides share a common tetrapeptide sequence 
with γ-MSH. Furthermore, the antiserum did not cross-react with N-terminal 
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POMC-derived peptides containing the γ-MSH sequence. Displacement curves 
obtained with the synthetic peptide (lys-y-MSH[l-8]) and with the extracts of 
neurointermediate lobes ran parallel. 
Immunocytochemistry 
Animals were anaesthetized by immersion in a solution of 0.1% tricaine 
methane sulphonate (MS 222; Sandoz, Switzerland) and transcardially perfused 
with cold 0.6% sodium chloride solution, carbogene-aerated to p H 6.9, for 5 
min, followed by perfusion fixation in Bouin's fluid, for 15 min. After dissection, 
whole pituitary glands were postfixed in the same fixative, for 3 h. Paraffin-
embedded, transversal (8 μιη) vibratome sections of the pituitary were mounted 
on poly-1-lysine-coated glass slides and used for immunocytochemical staining, 
unless stated otherwise. Sections were pretreated with 50 mM Tris-buffered 
saline (pH 7.6) containing 150 mM NaCl and 0.3% Triton X-100 (TBS-TX; Sigma). 
They were incubated in 20% normal goat serum (30 min) to prevent aspecific 
staining, and then exposed to rabbit γ-MSH antiserum (1:2,000) at 4°C for 18 h. 
The second antiserum was goat-anti-rabbit IgG (1:50; Nordic; Tilburg; The 
Netherlands), applied for 90 min. Finally, incubation was performed with rabbit 
peroxidase-antiperoxidase (PAP; 1:1,000; Nordic), for 90 min. All incubations 
and rinses were carried out in TBS-TX. 
Immunobinding was visualized by rinsing the sections in Tris-HCl 
(pH 7.6) and subsequent incubation in 0.04% 3,3'-diaminobenzidine 
tetrahydrochloride (DAB; Sigma), 0.25% nickel ammonium sulphate and 0.015% 
H 2 0 2 in 50 mM Tris-HCl (pH 7.6), for 40 min. The reaction was terminated by 
several rinses in Tris-HCl. Finally, slides were dehydrated and embedded. 
Specificity of the antiserum was demonstrated by preadsorption of the γ-MSH 
antiserum with the antigen. 
For comparative purposes immunocytochemical studies were extended 
to the rat pituitary. The pituitaries were rapidly dissected and fixed in Bouin's 
fluid. Further treatment was performed as described above. In addition, 
adjacent sections of both Xenopus and rat were immunocy tochemically stained 
using the method described above with an a-MSH antiserum that has been 
characterized previously (de Rijk et al., 1990b). 
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Radioimmunoassay 
Samples (HPLC fractions or neurointermediate or anterior lobe extracts) 
were resuspended in veronal acetate buffer (pH 8.6, 0.02 M sodiumbarbital, 
0.2 g/1 sodium azide and 0.3% bovine serum albumin; Sigma). The antiserum 
was used in a final dilution of 1:3,600 in the same buffer. Radioimmunoassay 
procedure was performed as described previously for a-MSH (van Zoest et al., 
1990). Bound and free antibodies were separated by precipitation with 15% 
polyethylene glycol and 2.4% ovalbumin. 
Molecular weight determination by electrospray ionization mass spectrometry 
The purified γ-MSH-immunoreactive peptides were analysed on a 
Bio-Q electrospray mass spectrometer (Fisons VG BioTech, Altrincham, UK) 
based upon electrospray ionization, using a quadrupole mass analyser with a 
maximum mass-to-charge (ra/z) limit of 4000. Lyophilized peptide was 
dissolved in 50% acetonitrile/1% formic acid in water; the final peptide 
concentration was approximately 1 μΜ (based on the theoretical molecular 
weight of the peptide). Samples of the purified peptide were introduced into 
the ion source by flow injection at a flow rate of 6 μΐ/min. Calibration was 
performed by prior mass analysis using horse myoglobulin (Sigma). 
Peptide sequencing 
Peptides were sequenced by automated Edman degradation in a model 
477 pulsed-liquid sequenator (Applied Biosystems, Foster City, CA, USA). 
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Results 
Electrophoresis 
Cysteine labelling revealed the presence of several peptides in the 
neurointermediate lobe with estimated molecular masses of 38 kDa, 18 kDa, 
9 kDa and 4 kDa (Fig. 1). With the exception of the 38 kDa peptide, these 
peptides are also present in the medium. The radioactivity of the 4 kDa peptide 
is about 10% of that of the 18 kDa and 9 kDa peptides. Glucosamine labelling 
resulted in the appearance of 38 kDa, 18 kDa and 9 kDa radiolabelled products 
indicating that these peptides are glycosylated. Tunicamycin treatment, which 
blocks N-linked glycosylation in POMC (Tkacz and Lampen, 1975; Martens et 
al., 1982), followed by cysteine labelling, induced a downward shift of 
approximately 3 kDa of the 38 kDa, the 18 kDa and the 9 kDa peptide, showing 
the glycosylated nature of these products. 
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Fig. 1 SDS ureum electrophoresis of 
neurointermediate lobes of Xenopus 
laevis and the products released 
after labelling with radioactive 
cysteine (in the presence or absence 
of tunicamycin) or with radioactive 
glucosamine. Lane (1) 
[35S]cysteine-labelled lobe and (2) 
secreted products, (3) marker 
peptides (46 kDa, 30 kDa, 21.5 kDa, 
14.3 kDa, 6.5 kDa), (4) the secreted 
products and (5) the extract of a 
[35S]cysteine-labelled tunicamycin 
treated lobe, (6) [3H]glucosamine-
labelled lobe and (7) secreted 
products. MW= molecular weight. 
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Immunocytochemistry 
Light microscope immunocytochemistry of the pituitary of Xenopus laevis 
revealed anti-y-MSH-immunoreactive material in the intermediate lobe of the 
pituitary (Fig. 2A) whereas both the posterior and the anterior lobe (including 
corticotrope cells) were immunonegative. Immunocytochemical staining of the 
rat pituitary revealed immunopositive cells in the intermediate lobe as well as 
in the anterior lobe (Fig. 2B). No staining was found with antiserum 
preadsorbed with synthetic γ-MSH. Adjacent sections of Xenopus and rat 
pituitaries show the presence of anti-a-MSH-immunoreactivity in melanotropes 
and corticotropes (Fig. 2C-D). 
Fig. 2 (A) Light microscopic staining of the pituitary gland of a black background-
adapted Xenopus laevis showing γ-MSH-immunoreactivity. Melanotrope cells of the pars 
intermedia are positive, while both the anterior and the posterior lobe are devoid of 
staining. (B) In the rat both melanotrope cells in the pars intermedia and corticotrope 
cells in the pars distalis are stained with the anti-y-MSH antiserum. Adjacent sections 
of Xenopus (C) and rat (D) pituitaries showing α-MSH-like immunoreactivity in 
melanotropes and corticotropes (PD=pars distalis, PI=pars intermedia, PN=pars 
nervosa). Bar= 100 μιη. 
56 
The N-terminal ofPOMC 
Reoersed-phase HPLC analysis 
Reversed-phase HPLC analysis of neurointermediate lobe extracts 
revealed two major immunoreactive peaks designated I and II, eluting after 10 
mm and 15 min, respectively (Fig. ЗА). Threonine is present three times in the 
γ-MSH moiety of POMC and was therefore used as a strong and specific label 
for the γ-MSH peptides. Incubation of neurointermediate lobes from black 
background-adapted X. laevis with radioactive threonine showed the 
biosynthesis of two peptides with the same retention times as the γ-MSH-like 
immunoreactive products I and II (Fig. 3B). Glucosamine incorporation 
followed by reversed-phase HPLC showed one major radiolabeled peak eluting 
at the same position as the first immunoreactive peak in the chromatographic 
profile (Fig. 3C). 
Fig 3 HPLC profiles of 
neurointermediate lobe 
extracts of black background-
adapted Xenopus laevis 
(A) Profile after radio­
immunoassay of each 0.5 mm 
fraction for γ-MSH, (B) after in 
vitro radiolabelling of 
neurointermediate lobes with 
[3HIthreonme and (C) after in 
vitro radiolabelling with 
[3H]glucosamine. I and II 
indicate the elution positions 
of the major γ-MSH-like 
immunoreactive products. 
lime (mm) 
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Fig. 4 Profiles of the electrospray mass spectrum of the purified γ-MSH-like products 
I and II as indicated in Fig. 3. (A) A profile of product I showing the MH6 6 +(A6) and 
MH7
7 +(A7) values and the calculated molecular weight (upper right corner) resulting 
in a molecular weight of 5005.58 ±1.6 and (B) a typical electrospray mass profile of 
product II showing the MH 2
2 + (A2), MH 3 3 +(A3) and MH 4 4 +(A4) values and the 
calculated molecular weight (upper right corner) of 1655.88 corresponding to γ,-MSH. 
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Electrospray mass spectrometry 
Products I and II (Fig. ЗА) purified to apparent homogeneity by a two 
step HPLC procedure, were subjected to electrospray mass spectrometry. This 
revealed a molecular weight of 5005.58 ± 1.60 for the immunoreactive peptide 
eluting first from the HPLC column (peak I, Fig. 4A). In addition, a small amount 
of another product was found with a molecular weight of 5049.80 (Fig 4A, 
arrow). In the profile resulting from the product in peak I a m/z (mass-to-
charge) peak of 366 Da was found (result not shown), suggestive for the presence 
of a dihexose compound frequently found in electrospray mass spectra of 
glycopeptides. The second peptide (peak II) gave a molecular weight of 1655.88 
± 0.10, which is in agreement with the predicted molecular weight of the y-¡-
MSH molecule in Xenopus (Fig. 4B). 
Y. -MSH Ъ MSH 
Deduced 
Position Residue from 
DNA 
Deduced 
Residue from 
DNA 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
Lys 
Туг 
Val 
Met 
Thr 
His 
Phe 
Arg 
Tip 
Asn 
Lys 
(Phe)* 
Lys 
Туг 
Val 
Met 
Thr 
His 
Phe 
Arg 
Trp 
Asn 
Lys 
Phe 
Lys 
Tyr 
Val 
Met 
Thr 
His 
Phe 
Arg 
Trp 
Asn 
Lys 
Phe 
Gly 
Arg 
Arg 
.** 
Ser/Asn 
Thr 
Gly 
Asn 
Asp 
Gly 
Ser 
-**/Ser 
Thr/-** 
.** 
Tyr 
Lys 
Tyr 
Val 
Met 
Thr 
His 
Phe 
Arg 
Trp 
Asn 
Lys 
Phe 
Gly 
Arg 
Arg 
Asn 
Ser/Asn 
Thr 
Gly 
Asn 
Asp 
Gly 
Ser 
Asn/Ser 
Thr/Gly 
Gly 
Tyr 
Table 1 Automated Edman 
degradation of the two major 
immunoreactive forms of γ-
MSH, as purified by 
reversed-phase HPLC from 
the neurointermediate lobe of 
Xenopus laevis. *could not be 
detected due to amidation, 
"conclusive identification of 
these residues could not be 
made. 
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Peptide sequencing 
Peptide sequencing by Edman degradation of the peak I peptide revealed 
the sequence expected for 73-MSH according to Xenopus POMC cDNA (Table 
1). The amino acid residue 16 (asn) of y3-MSH could not be detected directly, 
probably because of the attachment of the glycogroup at this position. Probably, 
because of genome duplication in an ancestor of Xenopus laevis two POMC 
genes (POMCA and POMCg) are present and transcriptionally active in the 
pituitary gland. Differences in amino acid residues in the γ-MSH peptides of 
the two POMC genes are indicated in the table. This concerns the residues 17, 
24 and 25. The other purified γ-MSH-immunoreactive peptide (peak II) shared 
the amino acid sequence with the former peptide but was C-terminally 
shortened by 15 amino acids, revealing the sequence lys-tyr-val-met-thr-his-
phe-arg-trp-asn-lys (Table 1). This sequence is identical to the Yj-MSH sequence 
according to Xenopus laevis POMC cDNA, assuming the presence of the phe-
N H 2 residue, as implied by mass measurement. The yield of the C-terminal 
amidated amino acid is generally low and very often cannot be detected. 
O) 200 
Q. 
time (min) 
Fig. 5 HPLC profiles for γ-MSH-like immunoreactive peptides in the neurointermediate 
lobe of Xenopus laevis lobe extracts from black background-adapted (A) and white 
background-adapted (B) Xenopus show similar HPLC profiles concerning γ-MSH-
immunoreactivity. Data are the average of four values -SEM. 
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Analysis of white and black background-adapted animals 
The total amount of γ-MSH peptides present in the neurointermediate 
lobe of Xenopus laevis, as determined by radioimmunoassay, was 6.1 ± 0.2 ng 
(n=5) for black background-adapted animals and 5.8 +1.2 ng (n=4) for white 
background-adapted animals. HPLC analysis of extracts of neurointermediate 
lobes from black animals showed the presence of two major γ-MSH-
immunoreactive peaks, with the first peak eluting after 10 minutes and the 
second peak emerging after 15 min, which correspond to y3-MSH and Yj-MSH, 
respectively (Fig. 5A). Similar results were obtained with white background-
adapted Xenopus laevis (Fig. 5B). A third peak was found eluting after 13 min, 
which might reflect the presence of a small amount of y2-MSH. Reversed-phase 
HPLC of the medium following 1 h of in vitro superfusion of neurointermediate 
lobes revealed only one immunoreactive peak, emerging after 10 min, which 
represents the y3-MSH peptide (Fig. 6). No differences were found between 
media from lobes of black and white background-adapted X. laevis (Fig. 6A,B). 
No γ-MSH-immunoreactive peaks were found in extracts of the anterior lobe. 
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Fig. 6 HPLC profiles of γ-MSH-immunoreactive peptides released in vitro from 
neurointermediate lobes of black background-adapted (A) and white background-
adapted (B) Xenopus laevis. Only immunoreactive material eluting at the position of 
Yj-MSH (product I) was found. Data are the average of four values -SEM. 
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Discussion 
Previous studies have shown that the 38 kDa precursor protein POMC 
in the neurointermediate lobe of Xenopus laevis is processed into a number of 
smaller products (Jenks et al, 1988). One of these peptides has been identified 
as the 18 kDa N-terminal peptide (Martens et al, 1982; Ayoubi et al. 1990). In 
this study we investigated further processing of this peptide, which in mammals 
is thought to be an intermediate product of POMC-processing (James and 
Bennett, 1985; Bennett, 1986; EstivarLz et al, 1989; Birch et al., 1991). Since analysis 
of Xenopus POMC cDNA has revealed that cysteine is only present in the 
N-terminal part of POMC (Martens, 1986), cysteine was used as a label in the 
biosynthetic studies. Trypsin mapping of the cysteine-labelled 38 kDa POMC 
precursor and of the 18 kDa, 9 kDa and 4 kDa products confirmed that all 
peptides are derived from POMC (data not shown). In general, the asparagine 
residue within the amino acid sequence asn-x-thr (or asn-x-ser) is the site where 
a carbohydrate chain is linked to a peptide through an N-acetyl glucosamine 
(Sox and Hood, 1970). The occurrence of an N-glycosylation site in both the 
18 kDa and the 9 kDa peptide indicates the presence of the γ-MSH sequence in 
these peptides, because the only possible N-glycosylation site is at position 65 
of the γ-MSI I sequence. We propose that part of the 18 kDa N-terminal peptide 
is split into the 9 kDa peptide, and a fraction of this subsequently into a 4 kDa 
peptide, the latter representing the N-terminal peptide that remains after 
removal of the γ-MSH sequence from the 9 kDa peptide (Fig. 7). All of these 
N-terminal products are potential end products of the processing of POMC 
because they were all found to be secreted into the medium. This is in contrast 
to POMC itself, which was only found within the neurointermediate lobe. 
To start the identification of HPLC-pu rifled POMC-products, the peak I 
peptide was submitted to electrospray ionization mass spectrometry. With this 
method, which gives the molecular weights of peptides and/or proteins with 
a precision better than 0.01 % (Smith et al, 1990), two products with a molecular 
weight of 5005.58 and 5049.80 were detected. These products appeared to be 
the POMCA and POMCB y3-MSH peptides on the basis of amino acid 
sequencing. As the non-glycosylated y3-MSH of Xenopus has a calculated 
molecular weight of 3200 it is apparent that Xenopus y3-MSH must include a 
glycogroup with a molecular weight of over 1,800 and that both POMC products 
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have a similar degree of glycosylation. The presence of the 366 Da fragment in 
the mass spectrum reflects a hexose-hexose group, a fragment often generated 
from the glycogroup of glycopeptides (Duffin et al., 1992). 
POMCB 
» t i t f t 
_1ЖТ "I_ 
ttt tm t * T I T ^ I J 
I 
t t 
N-fragment ¿-MSH 
• 
I H » 
I =signal peptide 
• =cys 
i =dibasic 
Φ = t e t r a m e r e 
^ =AA d e l e t i o n 
t =AA substitution 
AE ^ a c e t y l a t i o n enzyme 
¿-End 
X 1 A c £ - E n d ( 1 - 8 ) 
f 
Η 
І»# У 
Λ 
Fig. 7 Schematic representation of the processing of POMC by melanotropes of the 
amphibian Xenopus laevis. The structure of the proopiomelanocortin gene was deduced 
from nucleotide sequence analysis (Martens, 1986) and the processing is based on the 
present and earlier biosynthesis studies (Martens et ai, 1982; Jenks et al., 1988; van 
Strien et ai, 1993a). The positions of amino acid differences between РОМС
л
 and 
POMCg are indicated by filled arrows and the single amino acid deletion in POMCA 
is indicated by an open arrow. The position of the asn-linked glycosylation is shown 
by an open circle. Sites where two or more basic amino acids occur are indicated by 
filled grey boxes. The black bar on γ-MSH peptides indicates the N-terminal lysine. 
The two products indicated in dotted lines have not been detected in Xenopus 
melanotropes or as secretory products and may represent short-lived intermediates 
in the processing event. The acetylation enzyme for the conversion of desacetyl-oc-
MSH to a-MSH is depicted to be associated with the cell membrane because acetylation 
of this peptide is associated with secretion (Jenks et al, 1988; Dores et ai, 1991 ) whereas 
acetylation of ß-endorphin is mtracellularly (Martens, 1986; Dores et ai, 1991). The 
exact location of the enzymes is unknown. The amino acid tetramere specific for the 
MSH peptides is indicated by radial filled boxes. Only 5-10% of the precursor is 
eventually processed to γ-MSH peptides, leaving the 18 kDa and 9 kDa N-terminal 
peptides as major end products. Abbreviations: AC, acetyl; ACTH, adrenocorticotropic 
hormone; AJP, acidic joining peptide; ß-End, ß-endorphin; CLIP, corticotropin-like 
intermediate lobe peptide; dAC, desacetyl. 
The molecular weight of the second immunoreactive product was in 
full agreement with the predicted molecular weight of lys-Yj-MSH-NHj of 
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Xenopus. Conclusive identification of the peptide was obtained by amino acid 
sequencing, which revealed the sequence of lys1-y1-MSH. This sequence is 
identical with the predicted sequence of Yj-MSH as deduced from X. laevis 
POMC cDNA (Martens, 1986). While lys-y2-MSH might be present as an 
intermediate product during the formation of Yj-MSH, the amount of this 
peptide will be very low. Processing of the C-terminal of lys-y2-MSH by removal 
of the glycine during amidation, is a process which also occurs during the 
formation of a-MSH. However, in contrast to the processing of POMC to form 
a-MSH, the N-terminal lysine of γ^-MSH is not removed by an aminopeptidase; 
Yj-MSH has been shown to be a poor substrate for aminopeptidases in a number 
of animal species (James and Bennett, 1985). 
The immunocytochemical analysis, showing the presence of γ-MSH-
immunoreact ive material in melanotropes but not in corticotropes, 
demonstrates the cell type-specific processing of POMC. In all vertebrates 
studied so far the presence of γ-MSH peptides has been reported in both the 
intermediate and the posterior pituitary lobe (Browne et ai, 1981; Ali-Rachedi 
et al., 1983; Bennett, 1985). Our antisera had no difficulty in detecting a-MSH 
peptides in rat corticotropes. Therefore, we conclude that the absence of 
immunocytochemical staining in Xenopus laevis corticotropes is not due to the 
methods used, but rather indicates a difference between Xenopus and other 
animals. This possibly reflects a difference in the amounts of processing 
enzymes between mammals and Xenopus (Braks et al., 1992; Zhou and Mains, 
1994). 
To obtain insight into the possible physiological significance of the 
γ-MSH peptides we examined neurointermediate lobes of white and black-
adapted animals. The biosynthetic activity of the pars intermedia in black 
animals is much higher than that of white-adapted toads (de Rijk et al., 1990b). 
This difference might have been reflected in a difference in the contents and/ 
or a difference in the release of the γ-MSH peptides from the neurointermediate 
lobes. However, no such difference was observed. Since it is known that these 
peptides have only weak melanotropic activity (Browne et al., 1981), other 
functions for γ-MSH and γ-MSH-containing peptides seem likely. Several studies 
have shown that they play a role in stress responses, namely affecting 
steroidogenesis in adrenals (Leboulenger et ai, 1986; O'Connell et al., 1993). 
Furthermore, there are indications for a physiological role of N-terminal POMC-
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peptides in adrenal regeneration (Estivariz et al., 1988a,b). 
Measurement of γ-MSH peptides present in the neurointermediate lobe 
of Xenopus laevis showed only small amounts when compared to other POMC-
derived peptides such as acetylated endorphin and cc-MSH. On a molar basis 
the concentration of γ-MSH peptides is up to 10 times lower than that of 
endorphins and oc-MSH (Dores et al., 1991; van Strien et al., 1993a). This result, 
in combination with the fact that the N-terminal 18 kDa and 9 kDa peptides 
are present in the medium, indicates that the latter peptides are major terminal 
products of processing that are secreted by the mclanotropes. Also in the rat, 
large N-terminal POMC-peptides have been reported to be important 
processing end products (Emeson and Eipper, 1986; Seger and Bennett, 1986; 
Birch et al., 1991). 
Finally, we conclude that in the pituitary gland of Xenopus laevis the 18 
kDa and 9 kDa peptides are intermediates as well as end products of the 
processing of POMC to γ-MSH peptides, with the cysteine-containing 4 kDa 
peptide representing the N-terminal peptide (see Fig. 7). Moreover, this study 
has shown that all 5 peptides present in the N-terminal of POMC are secreted 
into the medium and they can thus be considered true terminal products of 
processing. The fact that approximately 90% of the POMC precursor is 
processed only to the 9 kDa and 18 kDa terminal products highlights the 
importance of these peptides as secretory products of the melanotropc cell. 
This urges a more extensive search for a possible function of these peptides. 
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Abstract 
The use of matrix-assisted laser desorp t ion / ion iza t ion mass 
spectrometry (MALDI-MS) in identifying proopiomelanocortin (POMO 
processing products in melanotrope cells of the pituitary intermediate lobe of 
Xenopus laevis was explored. Mass spectra were obtained with such a high 
sensitivity of detection that the peptides could be identified in a single 
melanotrope cell. In addition to known POMC processing products of the 
Xenopus melanotrope cell, the presence of previously unidentified POMC-
derived peptides was demonstrated. Together these POMC processing products 
account for the entire length of the POMC precursor. Furthermore, Xenopus 
possesses two genes for POMC and the sensitivity and accuracy of the MALDI-
MS technique allowed identification of processing products of both the POMCA 
and POMCB gene. In addition, differences were obtained between the mass 
spectra of melanotrope cells from Xenopus laevis adapted to different conditions 
of background illumination. These results show that MALDI-MS is a valuable 
tool in the study of the expression of peptides in single (neuroendocrine) cells. 
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Introduction 
In amphibians, the melanotrope cells of the intermediate lobe of the 
pituitary gland secrete a melanotropic peptide, a-melanocyte-stimulating-
hormone (a-MSH), which causes pigment dispersion in dermal melanophores. 
Thus, the pituitary melanotropes play a pivotal role in the process of skin colour 
adaptation. In lower vertebrates, as in mammals, a-MSH originates from a 
high molecular weight precursor protein, proopiomelanocortin (POMC). Based 
on the cDNA nucleotide sequence, the complete amino acid sequence of POMC 
has been determined in various mammalian (Nakanishi et ai, 1979; Drouin 
and Goodman, 1980; Takahashi et al, 1981; Uhler and Herbert, 1983; Boileau et 
al., 1983; Patel et al, 1988) and non-mammalian vertebrates (Martens et al., 1985; 
Kitahara et ai, 1988; Hilario et ai, 1990; Salbert et al., 1992). Through tissue-
specific processing POMC can generate a number of bioactive peptides 
including adrenocorticotropic hormone (ACTH), α-, β-, and γ-MSH, ß-lipotropin 
(ß-LPH) and ß-endorphin (Eipper and Mains, 1980). 
The melanotrope cells of the amphibian Xenopus laevis are specialized in 
producing and secreting POMC-derived products. Although in some studies 
MSH peptides and endorphin end products (Rouillé et al., 1989; van Strien et 
ai, 1993a, 1995a) have been identified, little is known about the complete profile 
of POMC processing products within the melanotrope cell. The complexity of 
the POMC precursor makes identification of all processing end products using 
traditional biochemical methods extremely difficult. The common practice of 
analysing neuropeptides by radioimmunoassay becomes arduous when 
applied to entire profiles. Moreover, this method can only be used for known 
peptide families. The introduction of high-mass mass spectrometric techniques 
and particle-induced desorption/ionization methods for analysing intact 
biopolymers (Karas et ai, 1987; Karas and Hillenkamp, 1988; Hillenkamp et ai, 
1991) has resulted in the manufacturing of mass-specific analysers that (2) can 
detect peptides regardless of provenance and composition, (2) are fast and (3) 
can be used to characterize complete profiles in mixtures of different peptides 
(Jardine, 1988; Tsarbopoulos et ai, 1994). One of these techniques is the matrix-
assisted laser desorption/ionization mass spectrometry (MALDI-MS) (van 
Veelen et ai, 1993; Jiménez et ai, 1994; Li et ai, 1994) which enabled the 
measurement of complete peptide profiles in single cells without prior peptide 
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purification. For proteins of which the sequence is (largely) known, mass 
spectrometry permits a rapid, detailed confirmation of the sequence and the 
identification of possible protein modifications, e.g. acetylation, amidation, 
glycosylation and phosphorylation (Feistner et al., 1989). In the case of the 
Xenopus melanotrope cell, the majority of the peptides produced are derived 
from POMC (Martens et al., 1987). The complete amino acid sequence of this 
precursor has been deduced from its nucleotide sequence (Martens et ai, 1985). 
Xenopus possesses two different POMC genes, named POMCA and POMCB, 
which are similar (but not identical) in their amino acid sequences (Martens, 
1986). MALDI-MS would be an appropriate method to characterize the full 
peptide profile resulting from the processing of РОМСд and POMCß. 
Furthermore, because melanotrope cells of black background-adapted Xenopus 
laevis are very active in synthesizing and processing of POMC whereas 
melanotrope cells from white-adapted Xenopus serve as storage cells with an 
inactive biosynthetic apparatus (Weatherhead, 1983; de Rijk et al., 1990b), with 
MALDI-MS the hypothesis could be tested that cells from black-adapted 
Xenopus contain more (larger) POMC processing intermediates than cells of 
white-adapted Xenopus. The purpose of this study was (1) to identify the 
different POMC (РОМСд and POMCB) processing end products and (2) to 
elucidate possible differences in the contents of melanotrope cells from animals 
adapted to different environmental light conditions. This was done by MALDI-
MS, using single Xenopus melanotrope cells to prevent interference with other 
cell types present in the pituitary gland. 
Materials and Methods 
Animals 
Adult Xenopus laevis with a weight of approximately 35 g were obtained 
from our laboratory stock. Toads were kept under constant illumination on a 
black or a white background for at least 3 weeks at 22°C. They were fed trout 
pellets (Trouvit, Trouw, Putten, The Netherlands) once a week. 
Preparation of single cells 
The melanotrope cells of 8 animals were isolated from the pituitary 
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neurointermediate lobe as described previously (Scheenen et al., 1994a), with 
minor changes. In short, animals were anaesthetized for 15 min in a solution 
containing 0.1 % MS222 (Sigma; St. Louis, MO, USA) and 0.15% NaHC0 3 (pH 
6.8). After perfusing the animal with Xenopus Ringer's solution, containing 
112 mM NaCl, 2 mM KCl, 2 mM CaCl2 and 15 mM HEPES (Calbiochem; La 
Jolla, CA, USA; pH 7.4) to remove blood cells, lobes were dissected and 
incubated for 45 min in Ringer's solution without CaCl2 to which 0.25% (w/v) 
trypsin (Gibco, Renfrewshore, UK) had been added. Cells were subsequently 
dispersed in Ringer's solution by gentle trituration of the lobes with a siliconized 
Pasteur's pipette. The cells were readily identified on the basis of their 
characteristic round shape and used immediately for mass spectrometry. 
Sample preparation 
Before MALDI-MS only minimal sample preparation was necessary. The 
matrix used was 2,5-dihydroxybenzoic acid (DHB; Aldrich Chemie, Steinheim, 
Germany) dissolved at a concentration of 10 mg/ml in 0.1 % trifluoroacetic 
acid (TEA; Merck, Darmstadt, Germany). After deposition of 1 μΐ of the matrix 
on a stainless steel target, the cells were placed in the matrix solution. The 
sample was dried in a cold air stream before loading into the mass spectrometer. 
Calibration was performed using a mixture of bovine insulin and horse 
cytochrome с (Sigma). The acid matrix used to retain the products directly 
from the melanotrope cells produced sufficient ions to eliminate purification 
artifacts. 
Mass spectrometry 
The mass spectrometer used was a VISION 2000 (Finnigan MAT, Bremen, 
Germany). This is a reflectron time-of-flight (TOF) laser desorption instrument 
equipped with a nitrogen laser at 337 nm. The laser beam was focused by a 
quartz lens system to a spot size of 70 μιη in diameter. The ions generated were 
accelerated to a potential of 5 kV in the ion source and post-accelerated by a 
conversion dynode to a potential of 20 kV. The effective drift length of the 
instrument is 1.7 m. Ions were detected by a secondary electron multiplier and 
the signal was amplified and digitized by a high speed transient recorder linked 
to a 486 personal computer. Molecular weight data were collected and compared 
with computer-analysed POMC precursor fragments with known or predicted 
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molecular weight, using the "find mass" program (MacProMass, Beekman 
Research Institute of the City of Hope, Duarte, CA, USA). Mass measurements 
up to 5 kDa were reliable up to ± 3 Da. Therefore, a small search window can 
be used, resulting in fewer matches and consequently less ambiguity in 
identification. 
Results and Discussion 
This study is based on the rationale that molecular weight information 
is sufficiently specific to tentatively identify all peptides that are either known 
to be present or can be predicted to occur in a given cell or tissue. This approach 
reduces the number of peptides that have to be analysed by more rigorous, but 
also more laborious and time-consuming, methods. Prediction is on the basis 
of "classical" precursor processing through cleavage at consecutive basic amino 
acids or by processing at "consensus" sequence sites that are present around 
monobasic cleavage sites (Schwartz, 1986; Benoit et al, 1987; Gluschankof and 
Cohen, 1987). With single cells, especially with a homogeneous cell suspension 
such as the melanotrope cells of Xenopus laevis, that only express one major 
type of precursor molecule, mass accuracy becomes less important. 
Complete mass profiles of melanotrope cells 
The overview mass spectra of a single melanotrope cell from both white-
and black-background adapted Xenopus laevis revealed 20 to 25 significant ions 
(Fig. 1). Clean and reproducible mass spectra were obtained up to a molecular 
mass of 10,000 Da. Mass accuracy for the peptides was in most cases better 
than ± 1 Da. The peaks with larger deviation may include unresolved 
components. The width of the peaks at higher mass slightly decreases accuracy. 
The molecular weight data obtained in this study immediately 
pinpointed a number of the reported processing products of Xenopus POMC 
(Jenks et al, 1988; Rouillé et al, 1989; van Strien et al, 1993a), ultimately 
accounting for the entire length of the POMC precursor (see Table 1, Fig. 2). 
Both desacetyl-a-MSH as well as oc-MSH, ß-MSH and lys-yj-MSH could readily 
be identified. However, the oc-MSH peak was very small compared to the 
desacetyl-a-MSH peak. This abundance of the desacetyl-a-MSH peak over the 
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oc-MSH peak is in line with results obtained using radioimmunoassay for 
a-MSH (Verbürg-van Kemenade et al., 1987c; Dores et al., 1991; van Strien et al., 
1995a). 
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Fig. 1 Representative example of MALDI mass spectra from freshly isolated, single 
melanotrope cell of Xenopus laevis. Arrows indicate the position of identified POMC 
processing products (see Table 1). The spectra represent unprocessed data accumulated 
from 20 single-shot acquisitions without any filtering or background subtraction. (A) 
Spectrum from a melanotrope cell derived from a white background-adapted animal. 
(B) Spectrum from a melanotrope cell of a black background-adapted animal. Peak 4 
was present as a small peak partially overlapping with peak 3 and peak 13 was not 
always detected in the spectrum. At higher resolution the presence of these products 
was clearly visualized. 
As expected, only one ion was observed for each of the products, because 
these products show no difference in molecular weight whether derived from 
POMC A or POMCB. The a,N-acetylated-ß-endorphin[l-8] (POMC 229-236) was 
mainly present as sodium and potassium ions, resulting in shifts of 22.0 Da 
and 38.1 Da for the sodium and potassium ion, respectively. Thus, the measured 
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molecular weight of this peptide differs from the calculated molecular weight, 
showing shifts from 944.1 to 966.1 and to 982.2, respectively. This result was 
confirmed by running synthetic ct,N-acetyl-ß-endorphin[l-8] under the same 
conditions which resulted in the appearance of the 966.1 Da and 982.2 Da 
products, in the absence of the 944.1 Da H+-ion. Only small peaks were observed 
for all acetylated endorphins (viz. α,Ν-acetyl-ß-endorphin [1-8], [1-27] and 
[1-31]). Because it is known that the Xenopus melanotrope cells contain high 
amounts of a,N-acetyl-ß-endorphin[l-8] (van Strien et al., 1993a), acetylation 
of these endorphins may interfere with the matrix or with the ionization/ 
detection possibility of the mass spectrometer. Possibly due to the complexity 
of the peptide contents of the melanotrope cell the mass spectrometric signal 
of these peptides is suppressed and thus prohibits detection of all analytes. 
The mechanism of this suppression is unknown (see e.g. Nelson et al., 1994). 
Peptide Peak Nr. 
N-terminus1 
N-terminus 
N-terminus 
lys-Yj-MSH 
lys-Y3-MSH 
AJP 
Des-Ac-a-MSII 
a-MSH 
CLIP-fragment 
CLIP 
N-fragment 
ß-MSH 
Ac-ß-Ep(l-8) 
Ac-ß-EpU-271 
Ac-ß-Ep{l-31) 
2 
14 
15 
5 
13 
12 
3 
4 
6 
8 
9 
7 
1 
10 
11 
POMCA(POMCB) 
26-34 
26-73 
26-101 
75-86NH2 
75-101 
104-137 (104-138) 
[M+H+lc 
1070.2 
5139.7 (5183.9) 
MALDI-MS 
1069.4 
5139.1 (5182.7) 
ST >10,000 
1657.0 
ST 
3885.1 (4042.2) 
140-152NH2 (141-153NH2) 1607.9 
140-152NH2 (141-153NH2) 1649.9 
157-172 (158-173) 
157-178 (158-179) 
181-205 (182-206) 
210-226 (211-227) 
229-236 (230-237) 
229-255 (230-256) 
229-259 (230-260) 
1818.0 
2538.8 (2522.8) 
2895.1 (2965.1) 
2100.3 
944.1 
3125.6 (3139.6) 
3567.2 (3566.2) 
1656.0 
5006.8 (5050.2) 
3882.7(4041.5) 
1607.0 
1648.9 
1817.2 
2537.9 (2522.4) 
2897.2 (N1) 
2099.7 
966.4 (ST) 
3123.6 (3139.1) 
3566.8 (3564.8) 
• 
-0.8 
-0.6 (-1.2) 
-1.0 
+0.2(+0.4) 
-0.1 (-0.7) 
-0.9 
-1.0 
-0.8 
-0.9 (-0.4) 
+2.1 (N1) 
-0.6 
+0.3 (ST) 
-2.0 (-0.5) 
-0.4 (-1.4) 
Table 1 Summary of mass data of identified POMC processing products obtained from 
Xenopus melanotrope cells. Peak numbers are related to the peaks as shown in Fig. 1. 
Amino acids 1-25 of the POMC precursor form the signal peptide, which is generally 
not found. The complete POMCA precursor comprises 259 amino acids (260 for 
POMCB; Martens, 1986). The position of the peptides within the precursor and the 
calculated average molecular mass for POMCA (and POMCB) processing products 
have been indicated, as well as the molecular weight products found by MALDI-MS 
in melanotrope cells. • indicates the difference between calculated average mass and 
measured molecular mass of the protonated ions. Ac=acetyl, AJP=acidic joining 
peptide, NI=not identified, ST=see text. 
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Although the absence of a signal does not prove that a peptide is not 
there, the absence of nonacetylated endorphins in the melanotrope cells 
confirms previous findings (Martens et al, 1981b; van Strien et al., 1995a). These 
results support the observations concerning the spatial difference in acetylation 
of a-MSH and endorphins, while the endorphins are rapidly acetylated after 
synthesis (so, no nonacetylated endorphins can be found within the cell), 
acetylation of desacetyl-oc-MSH occurs at the moment of secretion, which 
explains the small amount of a-MSH present within the cell (Martens et al, 
1981b; Verburg-van Kemenade et al, 1987c; Jenks et al, 1988; Dores et al, 1991). 
Different POMCA and POMCB processing end products 
Several peptide products, unique to either the РОМСд or the POMCg 
gene, were found. Only small differences in the height of the peaks of POMC A 
and POMCg end products were visible, indicating similar amounts of РОМСд 
and POMCg end products and a similar processing. This is in agreement with 
the biosynthesis and the level of expression of the two POMC genes (Martens, 
1988). 
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Fig. 2 Schematic representation of the РОМСд precursor of the amphibian Xenopus 
laevis. The structure of the POMC gene was deduced from nucleotide sequence analysis 
(Martens et al., 1985). Positions of amino acid differences between РОМСд and POMCg 
are indicated by filled arrows and the single amino acid addition in POMCB is indicated 
by an open arrow. The position of the glycosylation is shown by the open circle. Sites 
where two or more basic amino acids occur are indicated by filled boxes. Processing 
products formed via processing at dibasic amino acids are indicated by horizontal 
lines. AA = amino acid. 
The corticotropin-like intermediate peptides (CLIPs) derived from 
РОМСд and POMCg have a difference in molecular mass of only 18 Da, but 
both peptides were clearly present (Fig. ЗА). Interestingly, no evidence for 
posttranslational modification of this product in Xenopus laevis melanotropes 
could be obtained, although it has been shown that both rat and human CLIP 
can be phosphorylated as well as glycosylated (Bennett et al, 1982,1983). Two 
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different peaks were also observed to match the N-terminal 26-73 peptide of 
the two POMC genes (N-terminus2; Fig. 3B). These peptides were the most 
favourable matches for the ions seen, with average molecular weights of 5139.1 
and 5182.7, respectively. Recent biosynthesis studies have shown that this N-
terminal peptide is a secretory product rapidly formed from a larger γ-MSH-
containing POMC product (van Strien et al., 1995b). 
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Fig. 3 MALDI mass spectrum 
from a single melanotrope celi 
confirming the presence of both 
POMCA and РОМС
в
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products. (A) Corticotropin-like 
intermediate peptide from 
POMC 
from 
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peptide (POMC 26-73) derived 
from POMCA ([M+H+] c = 
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5183.9). The spectra represent 
unprocessed data accumulated 
from 10 single-shot acquisitions 
without any filtering or 
background subtraction. 
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γ-MSH peptides in Xenopus melanotropes 
The POMC precursor protein of Xenopus laevis contains only one 
glycosylation site, which is present in the γ-MSH region (Fig. 2) (Martens, 1986). 
Nevertheless, cleavage near this site results in several peptide products 
containing the glycogroup (lys-Y3-MSH and the N-terminal peptides containing 
this γ-MSH). Since glycopeptides are not always seen in mass spectrometry 
(Jardine, 1988) and since the carbohydrate structures of the intermediate 
glycopeptides are not known, the identification of these peptides is not straight 
forward. Nevertheless, both Р О М С
л
 lys^-MSH and POMCB lys^-MSH have 
been isolated and their molecular weights identified by electrospray mass 
spectrometry (van Strien et al., 1995b). Although only small peaks were found 
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in the melanotrope cells, the molecular weights for the lys-Y3-MSH peptides 
have now been confirmed by MALDI-MS. Consistent with earlier reports 
(Bohlen et al, 1981; Hammond et al., 1982; Mains et al, 1983) we observed lys-
γ-MSH and not γ-MSH. Apparently, the dibasic arg-lys is used as a monobasic 
processing site and processed at very low pace. It remains an unanswered 
question as to why the cleavage procedure for lys-y-MSH is so different from 
that occurring at other other dibasic sites. 
Unexpected POMC peptides 
The usefulness of the "find mass" program for the recognition of 
unexpected peptides was demonstrated for C-terminally shortened forms of 
CLIP, of the so called N-fragment (POMC 181-207), and of the N-terminal 
peptide (POMC 26-73, N-terminus2). On the basis of the computer analysis the 
C-terminally truncated CLIP (POMC 157-172) is the peptide with a molecular 
weight of 1817.2 (peak 6). Furthermore, C-terminally shortened products of 
the N-terminal (N-terminus1) and the N-fragment were found to fit ions (peak 
2 and 9) in the mass spectrum. CLIP, the N-terminal peptide and the N-fragment 
are both acidic and contain high molecular percentages of proline, glutamic 
acid, aspartic acid and threonine. This fact has been linked to fast proteolytic 
degradation in vivo (Rogers et al, 1986) and explains the presence of the 
truncated forms of the N-fragment, the N-terminal and CLIP in this study. 
Unidentified products 
Some peaks could not be identified as POMC processing products by 
MALDI-MS (MW 1388.9, 2002.2, 2422.3). Possibly, these peaks represent 
posttranslationally modified POMC end products (.e.g. by amidation, 
acetylation, phosphorylation or glycosylation). Alternately, they may be non-
POMC peptides produced by the Xenopus melanotrope cell. The post source 
decay technique, which is currently in a developmental stage, will probably 
allow the extraction of sequence information from these products (Spengler et 
al, 1992). Other POMC peptides deduced by computer analysis matching ions 
present in the spectrum were judged by us to be poor candidates either because 
they (1) contain dibasic cleavage sites not expected to survive in the intermediate 
pituitary or (2) their processing would require the unlikely cleavage of a dibasic 
cleavage site next to a proline (Martinez and Potier, 1986). 
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Background adaptation 
Although the MALDI-MS profiles of cells derived from black 
background- adapted animals (Fig. 1 A) and those of white background- adapted 
animals (Fig. IB) showed little qualitative difference, the relative intensity of 
several peaks was quite different. Major differences were found, for instance, 
in the higher molecular weight region, where the 10 kDa product (peak 15, 
N-terminus3) was more pronounced in cells derived from black animals 
compared to the peak in cells of white-adapted toads. This ion might be 
identified as a POMC processing product. The N-terminal processing product 
of POMC (POMC 26-101, N-terminus3) contains the lys^-MSH and has a 
molecular weight of 10 kDa. Previous findings have reported the existence of 
large intermediates in the processing of POMC to its end products in 
melanotrope cells from black background-adapted Xenopus (Martens et al., 1987) 
and such a N-terminal product has been identified as a major processing 
product on SDS gel electrophoresis (Bohlen et ah, 1981). It seems likely that the 
10 kDa ion (N-terminus3) is this product. Some other products in the mass 
profile with a lower molecular weight (peak 2 and an unidentified molecular 
ion at m/z 1388.9) were more pronounced in melanotrope cells of white-adapted 
Xenopus than in cells of black-adapted animals. The physiological significance 
of this difference in processing end products is not known. However, these 
findings are in agreement with the idea that melanotropes of black background-
adapted animals are very active in the biosynthesis and processing of POMC 
and thus will contain larger intermediates, while melanotropes of white 
background-adapted animals serve as storage cells, containing completely 
processed POMC end products (de Rijk et ah, 1990b; Nelson et al., 1994; van 
Strien et al, 1995b). 
Conclusions 
Single pituitary melanotrope cells can be efficiently charted by MALDI-
MS and reveal a complete spectrum of the POMC-derived peptides. Although 
the samples are initially in a physiological environment, neither sample 
pretreatment nor separation steps are necessary. This offers a fast screening 
which is minimizing artifacts caused by extraction or separation procedures of 
conventional methodologies, and offers the possibility to directly mass analyse 
proteins present in naturally occurring biological fluids. All previously 
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identified and several new POMC end products in melanotrope cells of Xenopus 
iaevis were identified by the MALDI-MS method. In addition, the differences 
in processing end products of POMCA and POMCB could be resolved. While 
little can be said of the absolute concentration of the peptides in the profiles, 
clear differences between the relative intensities of the peaks show that MALDI-
MS can be used to demonstrate different peptide contents in melanotrope cells 
from animals under different physiological conditions. 
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Abstract 
Melanotrope cells in the pituitary pars intermedia of amphibians 
synthesize and secrete peptides derived from the precursor protein 
proopiomelanocortin (POMC). To characterize peptide secretion from 
melanotrope cells of Xenopus laevis, neurointermediate lobes were labelled with 
35S-methionine and then release of radiolabelled peptides was followed during 
subsequent superfusion of the radiolabelled tissue. Two phases in the secretion 
of radioactive POMC-derived peptides were observed. The first phase 
represents the release of newly synthesized peptides and shows a rapid and 
sharp increase reaching a maximum about 3 h after the start of superfusion, 
followed by a rapid decrease in the release. The second phase represents the 
release of mature peptides, which occurs in a more sustained manner. The 
effects of the secretion inhibitor dopamine and the secretion stimulator 
sauvagine (a peptide related to corticotropin-releasing hormone) were studied 
on the secretion of POMC-derived peptides, using a dual-labelling protocol 
whereby both phases of secretion were examined simultaneously. The results 
showed that dopamine blocks secretion of both newly synthesized and mature 
peptides, while only mature peptides are sensitive to stimulation by sauvagine. 
These observations indicate the existence of two independently regulated 
secretory pathways in the melanotrope cells of Xenopus laevis. 
82 
Independently Regulated Secretory Pathways 
Introduction 
The intracellular pathway involving biosynthesis, processing and 
trafficking of secretory proteins in endocrine cells has been well established 
(Burgess and Kelly, 1987). Ample evidence is available that endocrine and 
neuroendocrine cells contain more than one pathway through which they can 
secrete peptides (Keith et al, 1986; Chen et ai, 1989; Mena et al, 1989; Stachura 
et al., 1989). Most cells contain two secretory pathways, one with newly 
synthesized and the other with mature peptides. Furthermore, several reports 
indicate that release via those pathways is regulated independently (Schwartz 
et al, 1990; Stachura and Tyler, 1990; Gracia-Navarro et al, 1991). Abundant 
ultrastructural and biochemical evidence supports the contention that newly 
synthesized hormone is preferentially released under basal conditions over 
older (mature), stored products (Walker and Farquhar, 1980; Ham and Smyth, 
1985; Chen et al, 1989). However, most results are obtained with cells that 
produce only one peptide and the biological significance of these two pathways 
is as yet unknown. The possibility of an emergency pool, which would consist 
of mature peptides, only used when high amounts of peptides are suddenly 
requested, has been proposed by several groups (Stachura and Tyler, 1990; 
Noel and Mains, 1991). In contrast, in multipeptidergic cells, like the 
proopiomelanocortin- (POMC-) producing melanotropes of the pituitary pars 
intermedia, the existence of different pathways may enable the cell not only to 
regulate secretion quantitatively but also qualitatively, e.g. by releasing different 
peptides with different biological activities. In this way secretory cells would 
not only vary the way they act on a target cell but might also be able to change 
targets under changing physiological demands. 
POMC, the precursor of the bioactive peptides oc-melanophore-
stimulating hormone (oc-MSH), adrenocorticotropin hormone (ACTH) and 
ß-endorphin, is synthesized in the brain, where its peptide end products act as 
neurotransmitters (Bloom et al, 1978; Watson et al, 1978), as well as in the 
pituitary gland, where the peptides are stored before being released as 
hormones (Zakarian and Smyth, 1982). A well developed model for the study 
of POMC synthesis, processing and secretion is the melanotrope cell of the 
amphibian Xenopus laevis. This cell plays an important role in regulating the 
process of background adaptation (Jenks et al, 1988). In black background-
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adapted animals the cells display high biosynthetic and secretory activity, 
releasing a large number of POMC-derived peptides. Among these a-MSH 
hormonally stimulates pigment dispersion in the dermal melanophores thus 
causing darkening of the skin. The secretion of a-MSH and other POMC-
derived peptides from the melanotropes is under complex control of various 
hypothalamic factors (for review see Jenks et al., 1993). Innervation of the 
pituitary by the brain is mainly inhibitory and restrains the high spontaneous 
rate of peptide secretion characteristic of the melanotropes (Kongsamut et al., 
1991). Three inhibitory hypothalamic factors (dopamine, neuropeptide Y and 
γ-aminobutyric acid) have been localized in varicosities abutting the 
melanotrope cells in the pars intermedia of Xenopus laevis (van Strien et al., 
1991; de Rijk et al., 1992). Several stimulatory agents (corticotropin-releasing 
hormone, thyrotropin-releasing hormone and acetylcholine) are also present 
in the vicinity of the melanotropes (Verburg-van Kemenade et al, 1987a,b; Jenks 
et ah, 1988; van Strien et al., this thesis). 
A possible reason for the action of multiple regulatory factors on Xenopus 
melanotropes could be that they have different effects on secretory 
compartments within the neurointermediate lobe, i.e. different factors could 
regulate the release of different peptides from the melanotrope cells. In case of 
the neurointermediate lobe of Xenopus laevis pulse-chase analysis has shown 
that peptides derived from POMC are released in two phases that might 
represent two different secretory pathways: a fast phase in which peptides are 
released within 6 h after their biosynthesis (newly synthesized peptides) and a 
slow phase concerning peptides that remain intracellularly for many hours 
before release (mature peptides) (Martens et al., 1981a; van Zoest et al., 1990). 
These different secretory phases might contain different POMC endproducts, 
thus explaining the complex regulation of secretion. In this study we have 
examined the action of the amphibian secretion stimulator sauvagine and the 
secretion inhibitor dopamine on the different secretory phases. For this purpose 
we have used a dual-labelling protocol where release of both newly synthesized 
peptides and mature peptides was followed simultaneously. The results show 
that while dopamine inhibits both phases of secretion only the mature peptides 
are sensitive to stimulation by sauvagine, thus indicating that the two phases 
of secretion are independently regulated. 
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Materials and Methods 
Animals 
Adult Xenopus laevis with a weight of approximately 35 g were obtained 
from our laboratory stock. Toads were kept under constant illumination on a 
black background at 22°C for at least 3 weeks and fed trout pellets (Trouvit, 
Trouw, Putten, The Netherlands) once a week. 
Release of radiolabelled peptides 
Neurointermediate lobes from black background-adapted animals were 
radiolabelled for 1 h in 100 μΐ methionine-free Leibovitz L-15 medium adapted 
to Xenopus osmolality and containing 100 цСі 35S-methionine (Amersham, 
Buckinghamshire, UK), washed and then superfused (1.6 ml/h) using complete 
Xenopus laevis L-15 medium (XL L-15). Fractions of 30 min were collected, the 
peptides in each fraction were isolated and separated from unincorporated 
35S-methionine using reversed-phase cartridges (van Zoest et ah, 1990), and 
radioactivity was determined. Results are expressed as the average of four 
individual lobes (-SEM). After superfusion neurointermediate lobes were used 
for HPLC analysis of the radiolabelled peptides still present in the lobes. 
Separation on reversed-phase HPLC was performed as described previously 
(Martens et al, 1980). 
Dual-labelling of neurointermediate lobes 
Neurointermediate lobes were rapidly dissected from black background-
adapted Xenopus and radiolabelled for 15 h with 3H-methionine (Amersham; 
100 μΟ in 100 μΐ methionine-free XL L-15), washed, and chase-incubated in 
complete XL L-15 medium for 24 h to allow for the maturation and the release 
of the newly synthesized peptides. The lobes were then radiolabelled with 
35S-methionine (100 цСі) in 100 μΐ methionine-free XL L-15 for 1 h and 
superfused (1.6 ml/h) using Xenopus laevis Ringer's solution (Verburg-van 
Kemenade et al, 1987a) containing 1 mM L-methionine. Fractions of 15 min 
were collected, peptides isolated with reversed-phase cartridges and 
radioactivities associated with 3 H and 3 5S determined. Each experiment 
involved 4 lobes and the results were expressed as averages -SEM. 
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Results 
Pulse-chase analysis of the release of 35S-methionine-labelled POMC-
derived peptides from melanotropes revealed a phase, containing newly 
synthesized peptides, which reached a maximum 3 h after labelling and then 
decreased rapidly. This biphasic pattern of release of newly synthesized 
peptides was followed by a phase of low basal release which continued for 
over 24 h (Fig. 1). HPLC-analysis of the lobes after superfusion (Fig. 1, insert) 
showed the presence of sufficient radiolabelled peptides to allow for secretion 
of these mature peptides for at least 3 days. Many of the radioactive products 
present could be identified as POMC-derived peptides (a-MSH, γ-MSH, CLIP, 
ß-endorphin-related peptides) on the basis of their elution position. 
HPLC analysis 
7 5 10 12 5 15 17 5 20 22 5 25 27 5 
superfusion time (hours) 
Fig. 1 Release of 35S-methionine-labelled peptides from superfused neurointermediate 
lobes of Xenopus laevis. Two phases (newly synthesized and mature) in the secretion 
are indicated in the figure. The estimate that the release of radioactive peptides would 
be maintained for 3 days is based on the amount of radiolabelled peptides remaining 
in the lobe following superfusion as revealed by HPLC. The rate of release at the end 
of the superfusion was 15 χ 103 ± 12 χ IO2 DPM/h/lobe and the amount of radiolabelled 
peptides remaining in the lobes was 88 χ IO4 ± 9 χ IO4 DPM. N=4 (-SEM). Insert: 
HPLC profile of radioactivity remaining in one of the lobes following 28 h of 
superfusion. The free methionine (Met) and its contaminant (C) (±7% of total 
radioactivity) were disregarded in the determination of total radioactivity associated 
with the peptide fraction. 
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The study on the effect of secretagogues on secretion of POMC-derived 
radiolabel led pept ides was performed using dual-radiolabel led 
neurointermediate lobes. The results show that the mature 3H-labelled peptides, 
synthesized 18 h before initiation of the superfusion, have a low basal secretion. 
The release of 35S-methionine-labelled peptides, derived from a pulse labelling 
just before placing the lobes in superfusion, showed the typical biphasic pattern 
of release of newly synthesized peptides (Fig. 2). A pulse of sauvagine clearly 
stimulated the secretion of mature 3H-methionine-labelled peptides, but hardly 
affected the release of newly synthesized 35S-methionine-labelled peptides. 
Dopamine on the other hand inhibited secretion of both 35S-methionine-labelled 
(newly synthesized) and 3H-methionine-labelled (mature) peptides. Also, a 
second pulse of sauvagine after the inhibition by dopamine (Fig. 2, lower profile) 
again stimulated 3H-labelled peptides but had no effect on the 35S-labelled 
peptides. 
Discussion 
The pathway for the biosynthesis and for transport of peptides between 
the Golgi complex and the plasma membrane has been well described (see e.g. 
Schwartz, 1991). As proposed previously, two regulated secretory pathways 
might be present in the melanotrope cells of Xenopus laevis (Martens et ai, 1981; 
van Zoest et ai, 1990). Evidence for the existence of these regulated pathways 
is provided by the present demonstration of the typical release profile of the 
Xenopus melanotrope, releasing a bulk amount of newly synthesized peptides 
within the first hours (first phase) followed by a sustained release of mature 
peptides (second phase). 
Total release of radioactive newly synthesized and mature peptides could 
be blocked almost completely by dopamine, thus establishing that both phases 
in the secretion are regulated (Martens et ai, 1981a; van Zoest et ai, 1990). In 
this study the attention was focused on the release profile of radioactive material 
from the melanotrope cells of Xenopus laevis and the effect of neuroregulatory 
factors (dopamine and sauvagine) on the release of the two secretory phases 
by measuring the release of both newly synthesized and mature peptides 
simultaneously. We show the presence of two phases in the release of POMC-
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derived peptides that may reflect different secretory pathways. 
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Fig. 2 Effects of sauvagine and dopamine on the release of 35S- and 3H-labelled peptides 
from the neurointermediate lobe of X. laevis. Results of two independent experiments 
are shown. Vertical bars indicate where sauvagine and dopamine are present in the 
superfusion medium. N=4 (-SEM). 
The first phase lasts about 6 h and contains peptides that are both formed 
and released rapidly, and are thus designated newly synthesized peptides. The 
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second phase concerns peptides that are secreted over a long period. Apparently 
these peptides are stored in the melanotropes before being slowly released. 
Furthermore, in this study it is shown that sauvagine differentially controls 
the two secretory phases, clearly stimulating the release of mature peptides 
but having hardly any effect on the release of newly synthesized peptides. 
Corticotropin-releasing hormone- (CRH-) like peptides such as sauvagine may 
in general be differential regulators of the release of newly synthesized and 
mature POMC peptides because a stimulatory action of these peptides on 
mature secretory pathways has been noted earlier (Kraicer et ah, 1985; Young 
et ah, 1986; Schwartz et al., 1991). In addition, in experiments involving 
mammalian pituitary cells and CRH the pattern of secreted peptides differed 
from the intracellular peptide patterns (Ham, 1986), which suggests that 
selective release can occur from granules of cells that contain different segments 
of POMC. In Xenopus laevis differences in peptide content of different secretory 
granules have been found (Roubos and Berghs, 1993). 
It is well established that a number of endocrine and neuroendocrine 
cells possess more than one secretory pathway or secretory phase (Hanley and 
Wellings, 1985; Chen et al, 1989). Generally, these pathways concern release of 
newly synthesized versus release of mature peptides, similar to the situation 
we show here for the melanotrope cells of X. laevis. A possible explanation for 
the existence of different secretory pathways in melanotrope cells may be found 
at the ultrastructural level. Two morphologically different granule types can 
be observed in the melanotrope cell of Xenopus laevis (de Rijk et al, 1990b; Roubos 
and Berghs, 1993). In black-adapted X. laevis most of the cells are very active in 
biosynthesis and secretion of POMC-derived peptides showing mainly electron-
dense secretory granules which likely contain newly synthesized peptides. 
White background-adapted animals contain melanotrope cells that are very 
inactive in their biosynthesis and secretion and thought to serve as a store of 
mature POMC-derived peptides (C.A.F.M. Berghs, unpublished data). These 
latter melanotropes are full of electron-lucent secretory granules. Therefore, 
the possibility exists that differential release of mature and newly synthesized 
secretory products is the result of release of different types of secretory granules. 
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Abstract 
The release of proopiomelanocortin-(POMC-) derived peptides from the 
melanotrope cells in the pituitary pars intermedia of Xenopus laevis is regulated 
by multiple inhibitory and stimulatory neurochemical messengers. In this study 
we examined the role of acetylcholine (ACh) in regulating melanotrope cell 
activity. The origin of ACh was studied in in vitro biosynthesis experiments, 
where it was demonstrated that dissociated melanotropes can synthesize ACh. 
Oscillations in the concentration of intracellular free calcium ions are thought 
to be the driving force for the secretion of POMC-derived peptides from Xenopus 
melanotrope cells. Dynamic confocal imaging of intracellular free calcium 
revealed that ACh increases both the frequency and the amplitude of calcium 
oscillations in single melanotrope cells in a concentration-dependent way. A 
technique was developed to study simultaneously the changes in intracellular 
calcium and the secretion of peptides from the same population of melanotrope 
cells. ACh concentration-dependently raises the intracellular free calcium 
concentration as well as the release of POMC-derived peptides. The actions of 
ACh on the melanotrope cell was mimicked by muscarine but not by nicotine, 
indicating the exclusive presence of a muscarinic cholinergic receptor. 
Furthermore, selective muscarinic receptor antagonists showed that the actions 
of ACh are mediated through an M^ -subtype muscarinic receptor. Using 
immunofluorescence cytochemistry in combination with confocal laserscanning 
microscopy muscarinic receptors were visualized on the surface of the 
melanotrope cell. It is concluded that ACh stimulates the release of POMC-
derived peptides from the Xenopus melanotrope cell in an autocrine way, via a 
muscarinic Mj receptor and changes in intracellular free calcium concentration. 
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Introduction 
The pars intermedia of the pituitary gland of Xenopus laevis is a suitable 
object to investigate the action of neurochemical messengers on hormone 
release. The Xenopus pars intermedia consists of a relatively homogeneous 
population of melanotrope cells that produce proopiomelanocortin (POMC) 
and secrete POMC-derived peptides, such as melanophore-stimulating 
hormones (α-MSH, ß-MSH, γ-MSH) and peptides of the ß-endorphin family 
(Loh and Gainer, 1977; Dores et ai, 1991; Jenks et ai, 1993; van Strien et al., 
1995). The melanotrope cells of Xenopus laevis are predominantly under 
inhibitory control by a number of hypothalamic factors, including classical 
neurotransmitters and (neuro)peptides (Verburg-van Kemenade et ai, 1986; 
Jenks et al., 1993; Shibuya and Douglas, 1993a). Dopamine, γ-aminobutyric acid 
(GABA) and neuropeptide Y (NPY) inhibit a-MSH release via synaptic 
transmission (de Rijk et ai, 1992), whereas thyrotropiri-releasing hormone (TRH) 
and corticotropin-releasing hormone (CRH), stimulate α-MSH secretion, 
probably by diffusion from the pituitary pars nervosa (Verburg-van Kemenade 
et ai, 1987a,b; Jenks et ai, 1993). 
There are indications that acetylcholine (ACh) is an important factor in 
the control of α-MSH secretion. In the amphibian species Rana pipiens and Rana 
ridibunda secretion of α-MSH is stimulated by ACh (Hadley and Bagnara, 1975; 
Lamacz et al., 1989) and intermediate lobe cells of the porcine pituitary gland 
depolarize upon addition of exogenous cholinergic agonists (Zhang and Feltz, 
1990). Furthermore, the mammalian pituitary is innervated by cholinergic fibres 
and pi tu i tary homogenates contain significant a m o u n t s of choline 
acetyltransferase and ACh (Gallardo et al, 1977; Barron and Hoover, 1983; Egozi 
et ai, 1988). In addition, rat corticotropic cells and the anterior pituitary-derived 
tumour cell line AtT20 synthesize and release ACh (Carmeliet and Denef, 1989), 
and more recently ACh biosynthesis was shown in the porcine intermediate 
lobe (Tandon et ai, 1991) suggesting the possibility of autocrine regulation of 
these intermediate lobe cells by ACh. On the basis of these data we have studied 
the possibility that ACh is involved in the autocrine control of secretory activity 
of Xenopus melanotropes. 
As no extrinsic cholinergic innervation of the pars intermedia of Xenopus 
laevis has been shown (Hopkins, 1971; de Rijk et ai, 1992), the first aim of this 
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study was to assess the capability of melanotrope cells to synthesize ACh. Then, 
the possibility was studied that ACh has an effect on the secretion of 
melanotrope peptides by modulating the intracellular concentration of free 
calcium ions ([Ca2+]¡). For this purpose, a combination of in vitro superfusion 
and calcium imaging (using confocal laserscanning microscopy) was developed. 
Finally, the ACh receptor was characterized pharmacologically and visualized 
by immunofluorescence microscopy. 
Materials and Methods 
Animals 
Adult Xenopus laevis with a weight of approximately 35 g were obtained 
from our laboratory stock. Toads were kept under constant illumination on a 
black or a white background, for at least 3 weeks at 22°C. They were fed trout 
pellets (Trouvit, Trouw, Putten, The Netherlands) once a week. 
ACh biosynthesis 
In order to study the possible biosynthesis of ACh in melanotropes, the 
method of Tandon et al. (1991) was adapted. In short, melanotrope cells of 8 
neurointermediate lobes were isolated (see below), centrifuged and 
resuspended in 200 μΐ Xenopus Ringer's solution (112 mM NaCl, 2 mM KCl, 
2 mM CaCl2,2 mg/ml glucose, 0.3 mg/ml bovine serum albumin and 1 μg/ml 
ascorbic acid, 15 mM HEPES; pH 7.4) containing 3H-choline (25 цСі, specific 
activity 69 Ci/mmol; Amersham, Buckinghamshire, UK) at 22°C. After 1 h, 
incubation was stopped by adding 500 μΐ of cold (4°C) Ringer's solution. After 
centrifugation, removal of the supernatant and washing to remove excess 
extracellular radioactive choline, cells were placed in 1 ml of cold 10% 
trichloroacetic acid (TCA) for 1 h. TCA was removed by washing 3 times with 
3 volumes of ether. Excess ether was evaporated and per 50 μΐ extract 5 μΐ 
portions of a 5% potassium iodide solution were added. Samples were 
lyophilized and subsequently redissolved in 150 μΐ 0.01 M sodium acetate/ 
citrate buffer (pH 5.0). Chromatographic separation was performed as described 
by Potter et al. (1984), using a Spectra Physics HPLC system and a BioRad RP-
C 1 8 column (250 χ 4.6 mm; Hemel Hempstead, UK). Aliquots of 100 μΐ were 
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injected. The mobile phase was 0.01 M sodium acetate/citrate buffer (pH 5.0) 
containing 1 % acetonitrile and 4.5 mg/1 sodium octyl sulphate (Sigma, St Louis, 
MO, USA), and flow rate was 0.8 ml/min. Column eluates were analyzed for 
radioactivity. 
Intracellular free calcium measurements 
In order to determine possible changes in the intracellular free calcium 
concentration (1Са2+]р in melanotrope cells, a cell preparation was made. After 
anaesthetization with 1% MS222 (Sigma), the animals were perfused with 
Ringer's solution to remove blood cells. They were decapitated, the 
neurointermediate lobe of the pituitary gland was rapidly dissected and rinsed 
4 times in culture medium (Leibovitz L-15 adapted to Xenopus osmolality, 
containing 10% fetal calf serum; XL-L15). Subsequently, the lobes were 
transferred into 1 ml dissociation medium consisting of Ringer's solution 
without CaCl2 and with 0.25 % (w/v) trypsin (Gibco, Renfrewshire, UK). Lobes 
were incubated for 45 min at 20°C and then triturated with a siliconized Pasteur 
pipette. Culture medium was added (9 ml), the cell suspension was filtered, 
and centrifuged for 10 min at 500 rpm. After removal of the supernatant, the 
cell pellet was resuspended in an adequate volume of culture medium (100 
μΐ/neurointermediate lobe equivalent). Then, cells were plated on cover slips 
coated with poly-1-lysine (Sigma; MW > 300 kD) in aliquots equivalent to 1 
lobe per cover slip, yielding approximately 10,000 cells /cover slip. Cell 
attachment was allowed for 16 h in an incubator, at 20°C. Then, 2 ml culture 
medium was added to each culture dish and cells were cultured for 2 days, at 
20°C. Melanotrope cells were readily identified on the basis of their 
characteristic round shape. Coverslips were placed in a Leiden chamber and 
the cells were loaded with the visible wavelength Ca -indicator fura-red by 
incubating in 6 μΜ fura-red AM (Molecular Probes, Eugene, OR, USA) in the 
presence of 1 μΜ pluronic F-127 (Molecular Probes), for 25 min at 20°C. Then, 
cells were washed with Ringer's solution by superfusion at a flow rate of 1 
ml/min, for 25 min, to remove non-hydrolysed dye (Scheenen et ai, 1994a). 
Optical sections of approximately 1 μπ\ thickness were studied with a BioRad 
MRC-600 confocal laserscanning microscope (Cambridge, UK). On-line 
measurements of fluorescence intensity for up to 14 cells per experiment were 
obtained, utilizing the fast photon counting set up of the MRC-600 and the 
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time-course ratiometric software package (TCSM, BioRad). Measurements were 
analyzed according to Koopman et al. (1996). Briefly, the data points collected 
were first inverted so that an increase in signal reflects an increase in [Ca2+]¡ 
(for fura-red a high [Ca2+]¡ gives a low fluorescence signal and vice versa). A 
linear fit line to the base of the signal was calculated and the data points of the 
signal line were divided by the points of the linear fit line, resulting in a new 
line with the data now normalized to 1. This procedure largely compensates 
for photo bleaching effects and, because of the normalization, the average of 
the relative [Ca2+]¡ signal of a number of cells can be calculated, even when 
they have different probe loading characteristics (and thus different fluorescence 
signal intensities). Secretagogues were introduced to the Leiden chamber by 
transferring the input line of the superfusion tubing to the Ringer's solution 
containing the secretagogue. The small air bubble introduced into the tubing 
during the transfer was pumped out via an inverted "T" joint in the Une, to 
prevent that the bubble would induce fluorescence artifacts by perturbing the 
cells. The overall effect of secretagogues on [Ca2+]i was assessed by averaging 
the normalized [Ca2+]¡ signal from 4 experiments involving measurements of 
at least 20 individual melanotropes. 
Combined analysis of secretion of POMC-derived peptides and [Ca2+]i 
The effects of ACh on [Ca2+]i and on secretion of radiolabelled POMC-
derived peptides were generally analyzed on the same set of cells. For that 
purpose, cells of 1.5 lobe equivalent were prepared as described above and 
suspended in 75 μΐ of lysine-free Leibovitz medium containing 22.5 μΟ 
3H-lysine (86 Ci/mmol; Amersham). The suspension was placed on a poly-1-
lysine-coated coverslip and the cells were allowed to attach for 16 h. After 
washing, cells were cultured for 2 days in complete medium. The coverslip 
was then placed in a Leiden chamber and the cells were loaded with fura-red 
for 25 min as described above. The chamber was superfused with Ringer's 
solution (1 ml/min) for 1 h before the experiment was initiated (with confocal 
microscopy analysis for [Ca2+]¡ measurements and the collection of 1 min 
fractions for analysis of secretion). One ml scintillation fluid (Optiphase TïïSafe', 
Wallac, Loughborough Leics., UK) was added to each collected fraction and 
the amount of radioactivity in each fraction determined in a liquid scintillation 
counter. Separate secretory studies had shown that approximately 30% of the 
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radioactivity in the superfusate is unincorporated 3H-lysine and that over 90% 
of the radiolabelled peptides are derived from POMC; this is in agreement 
with previous data (Scheenen et al., 1995). 
Analysis of secretion from neurointermediate lobes 
Experiments were conducted in which secretion of immunoreactive 
oc-MSH and, in some cases, radiolabelled peptides in combination with 
immunoreactive cc-MSH from whole lobes was analyzed. In the former 
experiments lobes were dissected out and placed immediately in 10 μΐ 
superfusion chambers, 1 lobe per chamber, and superfused at a flow rate of 2 
ml/h. Fractions of 7.5 min were collected and submitted to radioimmunoassay 
for a-MSH, as described previously (van Zoest et al., 1989). For the studies 
including radiolabelling, lobes were incubated in lysine-free Leibovitz medium 
with 10 % dialysed fetal calf serum, containing 22.5 цСі 3H-lysine (86 Ci/mmol; 
Amersham) for 18 h, washed 3 times and cultured in complete Leibovitz 
medium containing 10 % fetal calf serum (Gibco) for 2 days before superfusion. 
Receptor pharmacology 
To characterize the ACh receptor, the effects of various receptor agonists/ 
antagonists were analyzed on [Ca2+]¡ and secretion from cultured melanotropes. 
Pharmaca included muscarine chloride (a muscarinic cholinergic agonist), 
nicotine (a nicotinic cholinergic agonist), atropine (a muscarinic cholinergic 
antagonist), gallamine triethiodide (a M2 muscarinic receptor antagonist) and 
pirenzepine dihydrochloride (а Mj muscarinic receptor antagonist) (Sigma). 
Results of superfusion experiments are shown as the average of 4 experiments 
± SEM, unless stated otherwise. Percentages of stimulation of secretion in 
response to experimental treatment were calculated on the basis of the average 
levels of secretion of 3 fractions just before and the 3 fractions during the 
experimental treatment. 
Immunocytochemical demonstration of muscarine receptors 
Four animals were transcardially perfused with 30 ml 0.1 M sodium 
phosphate-buffered saline (PBS; pH 7.4), for 10 min. Then, perfusion was carried 
on with McLean's fixative as described by Benyamina et al. (1986), for 30 min. 
Brains with the attached pituitary glands were dissected out and postfixed for 
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3 h in McLean's fixative. The tissues were rinsed for 16 h in PBS containing 
15% sucrose and transferred to PBS with 30% sucrose, for 24 h. Sagittal sections 
(20 μπι) were cut with a cryostat, collected on glass slides coated with 0.5% 
gelatin, and processed for indirect immunofluorescence (Danger et al, 1985). 
In addition, isolated melanotrope cells were obtained from the lobes as 
described above and allowed to attach to the coated coverslips. Cells were 
fixed in McLean's fixative (1 h) and subsequently rinsed in PBS for 2 h. Further 
treatment was as described above. Cells were incubated for 16 h at 4°C with 
the monoclonal antibody M-35 raised in mouse against the calf muscarinic 
ACh receptor (André et al, 1984; Leiber et al, 1984), diluted 1:100 in PBS 
containing 0.3% Triton X-100 and 0.1% human serum albumin. Sections were 
rinsed in PBS for 1 h and incubated at 20°C for 1 h with fluorescein-
isothiocyanate-conjugated goat γ-globulin (dilution 1:60) raised against mouse 
immunoglobulin M (IgM; Nordic Immunological Laboratories, Tilburg, The 
Netherlands). Sections were rinsed, mounted in glycerine phosphate buffer 
(1:1; pH 7.4) and examined with a fluorescence microscope (Leitz, Rockleigh, 
NJ, USA) or examined with confocal laserscanning microscopy. 
Results 
Demonstration of biosynthesis of ACh by melanotrope cells 
Biosynthesis of ACh was studied in isolated melanotrope cells. 
Separation of the radiolabelled products formed after incubation with 
3H-choline resulted in the appearance of 3 radioactive peaks (Fig. 1A). The 
product that eluted after 10.5 min had the same retention time as 3H-choline. 
The product with a retention time of 12.5 min was isolated and the sample 
divided in 2 parts. One part was treated with acetyl Cholinesterase. HPLC 
analysis showed that the Cholinesterase almost completely converted the 
product into a 3H-labelled substance with a retention time of 10.5 min, which 
is the same as that of 3H-choline (Fig. IB). The other part served as a control 
and was not exposed to Cholinesterase. It eluted with a retention time of 12.5 
min (Fig. 1С), i.e. its initial elution position. In all HPLC runs a third product 
(retention time 8.5 min) was present. This product was not affected by acetyl 
Cholinesterase treatment. 
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3H-choline 
Fig. 1 Demonstration of de 
novo synthesized 3H-ACh m 
melanotrope cells of Xenopus 
laevis. (A) Separation of 
3H-radiolabelled products by 
reversed-phase HPLC 
following incubation of 
dispersed Xenopus laevis 
melanotrope cells with 
3H-chohne. The retention 
time of 3H-chohne standard 
is indicated (B) Treatment of 
the isolated 12 5 min product 
with acetylcholine esterase 
resulted in a conversion to a 
substance with a retention 
time of 3H-chohne (C) 
Control 12.5 min fraction 
resubmitted to HPLC 
without enzyme treatment. 
10 15 
HPLC elution time (mm) 
Effect of ACh on [Са2+]
г
 in single melanotrope cells 
Approximately 80% of the single melanotrope cells spontaneously 
displayed calcium oscillations, the other cells showed a relative constant [Са 2 + ]
г 
The frequency of these oscillations (up to 4 min"1) was highly variable among 
individual cells, but remained markedly constant for any given cell, for periods 
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up to 2 h. Adding ΙΟ"5 M ACh strongly increased the [Ca2+]¡ (Fig. 2A-C). Both 
the frequency and the amplitude of the oscillations were raised. Large 
differences were observed in the sensitivity to ACh among individual 
melanotrope cells, some cells not responding at all or only with a small increase 
in oscillation frequency (Fig. 2A), while other cells showed a strong stimulation 
in [Са 2 +^ oscillation frequency and amplitude. ACh induced calcium 
oscillations in non-oscillating melanotrope cells (Fig. 2B). The average relative 
change in [Ca 2 + ] i for 23 cells is shown in Fig. 2C. While oscillations cannot be 
seen in the averaged data, the results clearly show that the relative [Ca2+]j is 
strongly increased during addition of ACh. 
чдЬл ^ М 
Fig. 2 Effect of ACh (10"5 
M) on [Ca2+]¡ in single 
melanotrope cells in 
superfusion. (A) Example 
of ACh stimulation of both 
frequency and amplitude 
of Ca2+ oscillations in a 
melanotrope showing 
spontaneous oscillations. 
(B) Induction of [Ca2+]¡ 
oscillations in a non-
oscillating melanotrope. 
(C) The effect of ACh on 
[Ca2+]¡ averaged over 23 
melanotrope cells. A.U. = 
arbitrary units. 
10 15 20 25 
time (min) 
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Concentration-response experiments with ACh concentrations ranging 
from ΙΟ"9 M to ΙΟ"5 M show that ACh affects the [Ca 2 +] i in a concentration-
dependent manner. Some cells responded at a concentration as low as 10~9 M 
whereas others responded only at 10"5 M. At the latter concentration more 
than 90% of the cells responded. Fig. 3 shows the results for ACh at 10"7 to 
10"5 M. The results of 34 individual cells from 4 experiments were used to 
calculate the average [Са2 +]^ The result shows that ACh increased the [Ca 2 + ] i 
repeatedly and in a concentration-dependent way (Fig. 3B). Maximal increase 
in average relative [Ca2+]¡ was obtained at 10"6 M ACh. 
25 
acetylcholine 
107M Ю^М 1(Г5М 
single cell 
Fig. 3 C o n c e n t r a l o η -
response relationship 
between ACh and (I) 
[Ca2+]¡ and (II) release of 
radioactive POMC-
derived peptides, of single 
l melanotropes. 
(A) Example of ACh 
stimulation of frequency 
and amplitude of Ca2+ 
oscillations in a single cell. 
(B) The concentration-
response effect of ACh on 
[Ca2+]j averaged over 34 
melanotrope cells from 4 
experiments. (C) The 
concentration-dependent 
effect on the secretion of 
radioactive POMC-
derived peptides recorded 
simultaneously. Data are 
shown as the average 
-SEM of 4 individual 
experiments. A.U. = 
arbitrary units. 
80 
time (min) 
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Effect ofACh on peptide secretion 
ACh concentration-dependently stimulated secretion of radiolabelled 
products from isolated melanotrope cells (Fig. 3C). The first effect of ACh on 
secretion was clear at a concentration of 10"8 M, but stronger stimulation (40%) 
was achieved at a concentration of 10"6 M (Fig. 3C). All stimulations occurred 
rapidly and the secretion remained high throughout the period of ACh 
application. There was an indication for a biphasic response in secretion (a 
peak followed by a plateau), a pattern often reflected in the average Ca 2 + signal. 
Simultaneous measurements of the average change in relative [Ca 2 + ] i and the 
secretion of POMC-derived peptides showed similar temporal dynamics for 
both processes. 
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Fig. 4 Effect of ACh 
(IO"5 M) on the secretory 
process of neuro-
intermediate lobes. (A) 
Release of immuno-
reactive ot-MSH from 
freshly dissected lobes of 
white (open circles) or 
black background-
adapted (filled circles) 
Xenopus laevis. (Б) Release 
of a-MSH from lobes after 
3 days of culture, and (C) 
release of radioactive 
POMC-derived peptides 
in the same experiment. In 
each experiment N=4 
(-SEM). 
Administration of ACh in concentrations ranging from ΙΟ"9 M to ΙΟ"5 M did 
not change the level of a-MSH secretion from freshly dissected lobes of either 
black or white background-adapted animals. Fig. 4A shows the result of 
102 
Acetylcholine Autoexcites Melanotropes 
treatment with 10"5 M. This same treatment strongly stimulated the release of 
both a-MSH and radioactive peptides from lobes that had been cultured for 3 
days (Fig. 4B, C). No difference was obtained in the percentage of stimulation 
between immunoreactive a-MSH and radioactive POMC-derived peptides. 
muscarine 
1CT8M 1СГ5 M 
Fig. 5 Effects of ΙΟ 8 M 
and ΙΟ"5 M 
muscarine. (A) Effect 
on [Ca2+|j in a single 
melanotrope cell. (B) 
Effect on [Ca2+]i 
averaged over the 
results of 21 
melanotropes. (C) Ef­
fect on the release of 
radioactive POMC-
derived peptides in 
the superfusion me­
dium, expressed as 
percent basal release 
(-SEM). A.U. = 
arbitrary units. 
10 20 30 
time (min) 
Pharmacological characterization of the ACh receptor 
Muscarine mimicked the effect of ACh on intracellular calcium (Fig. 5A, 
B) as well as on secretion (Fig. 5C), where the effect on the average [Ca 2 + ] i was 
directly reflected by the effect on release of POMC-derived peptides. Both 
frequency and amplitude of the calcium oscillations were stimulated in a 
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concentration-dependent way, with a minimum effective dose of ΙΟ"10 M (where 
approximately 5% of the cells showed an increase in frequency of the 
oscillations) and a maximum stimulatory effect at ΙΟ"5 M (where more than 
90% of cells responded by increasing amplitude and frequency of calcium 
oscillations). The minimal concentration of muscarine showing an effect on 
secretion was ΙΟ"8 M (8% increase), whereas maximal stimulation of secretion 
was induced by ΙΟ"5 M muscarine (47%). Nicotine had no effect on either 
processes (Fig. 6A, B). 
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Fig. 6 Effects of ΙΟ"8 M 
and IO"5 M nicotine. (A) 
Effect on [Ca2+ |j in a 
D single cell showing 
spontaneous C a 2 + 
oscillations. (В) Effect 
on release of 
radioactive POMC-
derived peptides, 
expressed as percent of 
basal release (N=4 -
SEM). A.U. = arbitrary 
units. 
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The actions of ACh and muscarine on cultured melanotropes were completely 
abolished by the cholinergic antagonist atropine, which by itself had no effect 
on [Ca2"1"^ (Fig. 7A) or on secretion (Fig. 7B). 
104 
Acetylcholine Autoexcites Melanotropes 
atropine 10"6M 
2 5-
<, 
^ - 2 -
+ - 1 
CM 
CO 
О 
,> 
Я 
tí) 
Я 120 g 
Ъ 
го 
i . 100 
ω 
СП 
со 
ω во 
ел 6 0 
СО 
χι 
В 
Fig. 7 Effect of ΙΟ"6 M 
ACh in combination 
with IO"6 M atropine. 
(A) Effect on [Ca^lj in 
a spontaneously 
oscillating melanotrope 
cell. (В) Effect on 
secretion of radioactive 
P O M C - d e r i v e d 
peptides from cultured 
melanotrope cells, 
expressed as percent of 
basal release (N=4 -
SEM). A.U. =arbitrary 
units. 
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The specific Mj-subtype muscarinic receptor antagonist pirenzepine 
completely blocked the effect of muscarine on [Са 2 +] ; (Fig. 8A) as well as the 
stimulatory action of ACh on secretion (Fig. 8B). In contrast, the M2-subtype 
muscarinic receptor antagonist gallamine did not affect ACh-induced effects. 
When gallamine was added in combination with ACh, the frequency of the 
calcium oscillations was increased (Fig. 9A). The average [Са 2 + ] | was increased 
by ACh (Fig. 9B) which was reflected in a stimulation in the secretion of POMC-
derived peptides (Fig. 9C). Release of ct-MSH from freshly dissected 
neurointermediate lobes was not affected by muscarine, even at concentrations 
as high as ΙΟ"4 M (results not shown). 
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Fig. 8 Effect of ΙΟ'6 M 
ACh in combination 
with ΙΟ"6 M 
pirenzepine. (A) Effect 
on [Ca2 +], in a non-
oscillating melanotrope 
cell. (B) Effect on 
secretion of radioactive 
P O M C - d e r i v e d 
peptides from 3 days 
cultured melanotrope 
cells, expressed as per­
cent basal release (N=4 
-SEM). A.U. = arbitrary 
units. 
Immunocytochemical demonstration of muscarine receptors 
Fluorescence immunocytochemistry of the muscarinic receptor showed 
strong immunoreactivity in the Xenopus pituitary pars intermedia (Fig. IIA). 
Weak staining was present in the anterior part of the pars distalis, where the 
corticotrope cells are situated. Staining was virtually absent from the rest of 
the anterior pituitary and from the pars nervosa. Immunoreactivity in the pars 
intermedia appeared to be on the outside of the cells, however conclusive 
identification of the cell type containing the immunoreactive material could 
not be made. No staining was observed when either the primary or the 
secondary antibody was omitted. 
To elucidate the cell type containing the immunoreactivity for muscarinic 
receptors, immunostaining of single melanotrope cells was studied by confocal 
laserscanning microscopy. Fluorescence mostly appeared as patches (hot spots) 
on the cell surface (Fig. HB), and occasionally some staining in the melanotrope 
cytoplasm was observed. Over 80% of the melanotropes showed 
immunofluorescence on the outside of the cell. 
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gallamine 10~6 M 
Fig. 9 Effect of ΙΟ"6 M 
ACh in combination 
with IO"6 M gallamine. 
(A) Effect on [Ca2+]¡ in a 
single, oscillating 
melanotrope cell. (В) 
Effect on [Ca2+]¡ 
averaged over 29 
melanotrope cells. (C) 
Effect on secretion of 
radioactive POMC-
derived peptides from 3 
days cultured cells, 
expressed as percent 
basal release (N=4 -
SEM). A.U. = arbitrary 
units. 
time (min) 
Discussion 
ACh is produced by Xenopus melanotrope cells 
Although the amphibian pituitary pars intermedia is innervated by 
several neurons containing various neurochemical messengers including 
classical neuropeptides and neurotransmitters (Tonon et ai, 1992; Jenks et ai, 
1993; Tuinhof et al., 1994), no indications exist for the presence of a cholinergic 
neuronal system innervating the Xenopus pituitary (Hopkins, 1971; Verburg-
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van Kemenade et ai, 1986; de Rijk et ai, 1992). Our results showing that single 
melanotrope cells are capable of converting radioactive choline into a product 
that can be degraded by acetyl Cholinesterase to choline, indicate that Xenopus 
melanotropes synthesize ACh. Whereas it has been shown that rat corticotropes 
(Egozi et al., 1988), AtT 2 0 cells (Carmeliet and Denef, 1989) and cells in the 
porcine intermediate lobe (Tandon et ai, 1991) synthesize and release ACh, 
this is the first time that ACh biosynthesis has been demonstrated in the 
pituitary gland of a lower vertebrate. 
Fig. 11 Immunofluorescence staining using monoclonal antibodies against muscarinic 
receptors. (A) Distribution of immunoreactive material in the pituitary gland of Xenopus 
laevis. Bar = 50 μπι, PD = pars distalis, PI = pars intermedia, PN = pars nervosa. (B) 
Immunofluorescence signal obtained from two melanotrope cells by confocal 
laserscanning microscopy. Note patches of immunoreactive material on the outside 
of the melanotrope cell. Bar = 3 μιτι. 
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The results obtained with the amphibian Xenopus suggest that the 
production of ACh is a general property of POMC-producing cells, as the 
coexistence of ACh (or its synthesizing enzyme choline acetyltransferase) with 
POMC-producing cells was previously observed in corticotrope and 
melanotrope cells of mammals (Carmeliet and Denef, 1989; Tandon et ai, 1991). 
Recent electron microscopy studies in our laboratory have shown the 
presence of so-called synaptic-like microvesicles (SLMVs) in Xenopus 
melanotropes (C.A.F.M. Berghs and E.W. Roubos, unpublished observations). 
SLMVs have also been observed in various other endocrine cells (for review 
see Thomas-Reetz and De Camilli, 1994) and evidence is presented that in some 
cases they contain ACh (e.g. Bauerfeind et al., 1993). Therefore, the presence of 
such vesicles in Xenopus melanotropes is in line with the conclusion that 
melanotrope cells of Xenopus laevis produce ACh. 
ACh affects intracellular Ca2+ dynamics in melanotrope cells 
We studied the effect of ACh on [Ca2+]¡ to identify a role for ACh in 
melanotrope cell activity. Previously, it has been shown that Xenopus 
melanotropes display intracellular Ca2+ oscillations (Shibuya and Douglas, 
1993b; Scheenen et al., 1994a,b). ACh increased both the frequency and the 
amplitude of these oscillations. The concentration-dependency of the effect of 
ACh on changes in [Са2+]4 was examined using the same single cell, to avoid 
the problem that different cells will react in quantitatively different ways to a 
particular secretagogue (Shibuya and Douglas, 1993a; Scheenen et al., 1995). 
These studies show that ACh increases the Ca2+ oscillation frequency and 
amplitude in a concentration-dependent way and, moreover, induces Ca2 + 
oscillations in non-oscillating cells. Apparently, the melanotrope possesses a 
functional cholinergic receptor which is coupled to a system that controls the 
[Ca2+]¡, including the Ca2+ oscillatory mechanism. 
ACh stimulates melanotrope secretor}/ activity 
Ca2+ oscillations are thought to be the driving force for in vitro secretion 
of cc-MSH and of other POMC-related peptides from Xenopus melanotropes 
(Shibuya and Douglas, 1993b; Scheenen et al., 1994b). This idea is strongly 
substantiated by this study, in which we developed a method to measure 
intracellular Ca2+ dynamics as well as the release of POMC-derived peptides 
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simultaneously using the same cell preparation. ACh appears to stimulate Ca2+ 
oscillations and peptide release with similar dynamics, in a concentration-
dependent way, emphasizing the role of calcium oscillations as the driving 
force for secretion. 
No effect of ACh on freshly dissected whole lobes was found, an 
observation made earlier (Verburg-van Kemenade et ai, 1986). However, in 
experiments using neurointermediate lobes cultured for 3 days we show a clear 
stimulation in the release of POMC-derived peptides including oc-MSH. This 
difference between the response of fresh and 3 days cultured lobes may be 
explained by a difference in basal secretory activity of the NILs. It is known 
that freshly denervated lobes contain melanotropes that secrete at a very high 
rate, most likely because of the absence of inhibitory neural control exerted in 
vivo by the suprachiasmatic nucleus (Tuinhof et al., 1994). Apparently, ACh is 
not able to stimulate this high release any further. A similar situation occurs 
for the amphibian CRH analogue, sauvagine, which strongly stimulates the 
release of POMC-derived peptides from the melanotropes only when lobes 
have been cultured for at least 2 days (van Strien et al., 1993b). Presumably, 
during this period, secretory activity is reset to a more moderate level, allowing 
the stimulatory action of factors such as ACh, to become visible. 
The melanotrope cholinergic receptor is an M^-subtype muscarinic receptor 
To characterize the cholinergic receptor, superfusion and confocal-
imaging studies were performed using various pharmacological agents. 
Whereas muscarine mimicked the effect of ACh both on secretion and on [Ca2+1¡, 
nicotine had no effect on these melanotrope cell activities, excluding the 
involvement of a nicotinic acetylcholine receptor. The effect of ACh was blocked 
completely by atropine, indicating that the receptor is of muscarinic nature. 
Among the pharmaca acting on specific muscarinic receptor subtypes, only 
pirenzepine is effective in blocking the ACh effect. Therefore, it is concluded 
that the ACh induced effects on [Ca2+] i and secretion are mediated via an 
Mj-subtype muscarinic receptor. This is in contrast to melanotrope cells of Rana 
ridibunda and the porcine intermediate lobe cells which seem to possess both 
muscarinic and nicotinic receptors (Lamacz et ai, 1989; Louiset et ai, 1990; Zhang 
and Feltz, 1990; Gamier et ai 1994). 
The immunocytochemical studies showing immunofluorescence in the 
110 
Acetylcholine Autoexcites Melanotropes 
pars intermedia using an antiserum specific for the muscarinic receptor 
supports the conclusion that a muscarinic cholinergic receptor is involved in 
cholinergic control of Xenopus melanotropes. Confocal laserscanning 
microscopy on single cells revealed that the receptors are situated in a patch-
like manner on the surface of the majority (>80%) of the melanotropes. This 
might reflect the presence of clusters of receptors ('hot spots') in the plasma 
membrane, a phenomenon also observed for other receptors (Baker et al, 1992). 
The presence of fluorescent material in the cytoplasm of some cells might be 
due to recycling and/or de novo synthesis of ACh receptors. Immunoreactivity 
in the corticotropic region of the pars distalis of Xenopus laevis suggests that 
corticotrope cells of Xenopus also possess cholinergic muscarinic receptors. This 
conclusion is in agreement with the situation in mammals where ACh has been 
shown to regula te the secretion of corticotropes through activation of muscarinic 
receptors (Heisler et al., 1983). 
Conclusion: ACh autoexcites melanotrope cells 
This study shows that (I) the peptidergic melanotrope cells of Xenopus 
are able to synthesize the classical neurotransmitter ACh, (II) these cells possess 
M | muscarinic receptors, (III) ACh controls the [Ca2+]¡ of the melanotrope cells, 
and (Г ) the increase in [Ca2+]j is associated with an increase in secretion of 
POMC-derived peptides (Fig. 12). 
N-type 
melanotrope cell 
Fig. 12 Schematic representation of the melanotrope cells in the pars intermedia of 
Xenopus laevis, showing synthesis and mechanism of action of ACh as discussed in 
this paper. 
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On the basis of these data, we conclude that Xenopus melanotropes synthesize 
and release ACh, which increases secretion of POMC-derived peptides, 
including a-MSH, from this same cell type. In this way ACh might thus work 
in an autocrine/paracrine way. Possibly, through a paracrine mechanism single 
melanotrope cells can initiate a chain reaction of activation which spreads 
throughout the entire population of melanotrope cells. Further investigations 
are necessary to reveal the way in which ACh release from the melanotrope 
cell is regulated and to unravel the intracellular mechanisms responsible for 
the transduction of the receptor-mediated signal to the POMC secretory 
machinery. The latter mechanism might involve an IP3-mediated mechanism 
because Mj-subtype muscarinic receptors are known to activate the 
phospholipase С system, resulting in the release of IP 3 and a subsequent 
mobilization of Ca 2 + from intracellular stores (for review see Felder, 1995). 
Since it has been shown that Ca oscillations are propagated through the 
cytoplasm into the nucleus via the mobilization of intracellular Ca 2 + stores 
(Scheenen et ai, 1996), the changes in frequency and amplitude of [Ca 2 +] 4 
oscillations evoked by ACh may be involved not only in stimulating Ca 2 +-
dependent secretion but also in the control of other cellular processes, such as 
POMC biosynthesis and/or POMC gene expression (Loeffler et al., 1989; Al-
Mohanna et ai, 1994). 
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Xenopus melanotropes and proopiomelanocortin 
The physiological process of adaptation of the amphibian Xenopus laevis 
to the light intensity of its environmental background is a suitable phenomenon 
to study the basics of neuroendocrine communication. The studies described 
in this thesis concern the analysis of the secretory signal from the melanotrope 
cells of Xenopus laevis. These cells are the ultimate controllers of skin colour 
through the secretion of a-MSH. This peptide, which has been isolated from 
Xenopus melanotrope cells and sequenced (Rouillé et al., 1989), is one of the 
peptides derived from the precursor protein POMC. Previous studies on the 
melanotrope cells have shown the formation and secretion of various POMC-
derived peptides (Martens et al., 1980; Jenks et al, 1988) but none of these 
products has been sequenced. Therefore, it remained to be established whether 
all potential end products present in the POMC precursor are formed within 
the melanotrope cells and if they are secreted. In the studies presented here 
several POMC-derived peptides in the Xenopus melanotropes have been 
analyzed, using immunocytochemical methods for both localization and 
purification of the peptides and mass spectrometric methods for their conclusive 
identification. 
Endorphins and melanotropins 
An important group of potential POMC end products is constituted by 
the endorphins. The ß-endorphin moiety is located at the C-terminus of POMC. 
The present studies show that in Xenopus laevis melanotropes at least six 
products from the endorphin family occur. The most prominent form present 
in and released from the melanotrope cell is a peptide, newly identified in this 
study, namely ct,N-acetyl-ß-endorphin[l-8] (Chapter 2). This peptide, which 
has not been found in mammals, is derived from a larger endorphin product 
by cleavage at an unconventional monobasic cleavage site. The type of enzyme 
involved in the formation of this small endorphin is unknown as is the function 
of this peptide. 
Apparently, all endorphins in the Xenopus pituitary are acetylated rapidly 
after synthesis because no nonacetylated endorphins could be demonstrated. 
This is in sharp contrast to a-MSH which is mainly present in its nonacetylated 
form within the cell and becomes acetylated at the moment of secretion (Martens 
et ai, 1981b). The acetylated peptide is the major form in the secretory signal 
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(Chapter 3). On the basis of the above observations concerning the acetylation 
reactions two important conclusions can be drawn: (1) the endorphins released 
by the POMC-producing cells from the pituitary do not have an opioid function 
because only acetylated products are produced and it is well established that 
opioid activity is lost upon acetylation (Deakin et al., 1980), and (2) there is a 
spatial and temporal difference in the acetylation of endorphin and 
melanotropin. This latter conclusion strongly suggests that there is more than 
one acetylation enzyme present in the melanotrope cells, one for ß-endorphin 
and one for a-MSH. Furthermore, major differences were observed in the 
relative amounts of acetylated a-MSH in the secretory signal of white versus 
black background-adapted Xenopus laevis. The question arises as to whether 
these differences are due to a lack of acetylation enzymes (Verburg-van 
Kemenade et al., 1987c) or due to a differential secretion of acetylated versus 
nonacetylated peptides (cf. Maruthainar et al., 1992). Since the intracellular 
profile of melanotropins is not affected by the light intensity of the background, 
the relative amounts of desacetyl-a-MSH found to be released by melanotropes 
of white-adapted animals would appear to be due to a low cellular capacity to 
acetylate melanotropins. 
Other proopiomelanocortin-derived peptides 
Whereas the processing of the POMC precursor to the final a-MSH and 
endorphin end products occurs almost to completion, the N-terminal of POMC 
is not fully processed. Only a small portion of the N-terminal peptide seems to 
be processed to y^MSH, the final γ-MSH end product. Consequently, several 
different peptides containing the γ-MSH sequence are released by the 
melanotrope cells (Chapter 4). As proposed by others (Birch et ai, 1991), this 
incomplete processing might be due to the presence of a glycogroup within 
the γ-MSH peptide interfering with processing enzymes. A scheme for POMC 
processing in Xenopus melanotrope cells is presented in Chapter 4. This scheme 
is further substantiated in Chapter 5, where the analysis of a single melanotrope 
cell by means of matrix-assisted laser desorption/ionization mass spectrometry 
has been described. On the basis of the molecular weights found in this study, 
numerous POMC-derived peptides were identified. 
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Comments on methodologies used for peptide characterization 
The first four chapters of this thesis show the complexity of the secretory 
signal produced by the melanotrope cells as well as the importance of new 
detection methodologies for the analysis of peptide products. Isolating all these 
peptides and analyse their sequence would be a time consuming and expensive 
effort. In addition, amino acid sequencing is not always possible or does not 
give complete information about the peptide, i.e. in case of N-terminal 
acetylation or glycosylation. Recently, mass spectrometric techniques were 
introduced that can be used to identify small amounts of peptides on the basis 
of their molecular weight alone. Some of these techniques have been applied 
in the studies described in this thesis. To identify the products formed from 
the POMC precursor in melanotropes of Xenopus laevis mass spectrometric 
techniques are very helpful because the complete amino acid sequences of both 
the РОМСд and POMCB precursor are known from cDNA analysis (Martens 
et ai, 1986) and, therefore, molecular weights of peptides and peptide fragments 
can be compared to the amino acid sequences present in the precursor. Small 
purified products (< ca. 1,200 Da) can readily be identified by fast-atom 
bombardment mass spectrometry (Chapter 2), which also gives sequence 
information. Larger products can be identified by electrospray mass 
spectrometry, which is less sensitive to disturbing impurities (Chapter 4). 
Furthermore, to identify the products present in a mixture of peptides or in 
tissue/cell homogenates, matrix-assisted laser desorption/ionization mass 
spectrometry is the appropriate technique (Chapter 5), giving accurate 
molecular weight information of the main products present. All together, we 
conclude that the new mass spectrometric methodologies are extremely 
powerful tools for the analysis of peptidergic secretory cells. 
Regulation of the secretory signal 
The situation whereby a neuron or (neuro)endocrine cell produces a 
number of peptides, all derived from the same prohormone, but, presumably, 
each with an own biological activity, raises important questions concerning 
intracellular control mechanisms. Previous studies on Xenopus melanotropes 
suggested the existence of different peptide compartments within the 
melanotrope cells (Martens et al., 1981a; van Zoest et ai, 1990). Using a dual 
labelling protocol we now demonstrate differential control of the release of 
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mature versus newly synthesized peptides. The secreto-stimulator sauvagine 
only stimulated the release from the compartment with the mature peptides 
(Chapter 6), thus establishing that selective release of peptides from secretory 
compartments in the melanotrope cells is possible. 
During the past decade it was shown that the regulation of release from 
Xenopus melanotrope cells involves at least six neural messengers, viz. CRH, 
dopamine, GABA, neuropeptide Y, noradrenaline and TRH. In Chapter 7 this 
list of secretagogues is expanded with the demonstration that the 
neurotransmitter acetylcholine stimulates the release of POMC-derived 
peptides. The effects of acetylcholine both on changes in intracellular free cal­
cium and on secretion were studied simultaneously (Chapter 7). The results of 
this study considerably strengthen the idea that oscillations in intracellular 
free calcium are the driving force for secretion of POMC-derived peptides from 
Xenopus melanotrope cells. 
In our analysis of acetylcholine in the pars intermedia an interesting 
discovery was made, namely that this neurotransmitter does not reach the 
melanotropes via neural innervation but that the melanotropes themselves are 
the source of acetylcholine. This is a remarkable situation because acetylcholine 
is a classical neurotransmitter and production typically occurs in neuronal 
tissue. Our observations establish that the melanotrope cells are under 
autoexcitatory control by acetylcholine working through a muscarinic М
г 
receptor. A physiological role of acetylcholine could be the amplification of a 
stimulatory signal reaching the melanotropes. The observations from the lower 
vertebrate Xenopus laevis in combination with results obtained in mammalian 
endocrine cells indicate that autocrine/paracrine regulation by acetylcholine 
might represent a general phenomenon. 
It is hoped that the findings described in this thesis, providing a better 
insight into the secretory activity of the melanotrope cell of Xenopus laevis, may 
contribute to a better understanding of neuroendocrine communication 
mechanisms in general. 
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Om te overleven moeten organismen zich aanpassen aan hun omgeving. 
Een goede communicatie tussen cellen en organen is hiervoor essentieel. Bij 
deze communicatie zijn twee belangrijke systemen betrokken die nauw 
samenwerken: het zenuwstelsel en het endocriene systeem. Het belangrijkste 
knooppunt van deze neuroendocriene communicatie is de hypofyse, waar beide 
systemen samenwerken in de controle van perifere doelwitten die 
verantwoordelijk zijn voor de regulatie van, onder andere, groei, voortplanting, 
water- en ionenhuishouding en aanpassing aan de omgeving. Een interessant 
model om de samenwerking tussen het zenuwstelsel en het endocriene systeem 
te bestuderen is de melanotrope cel in de hypofyse van de klauwpad Xenopus 
ïaevis. Het in dit proefschrift beschreven onderzoek betreft de analyse en de 
regulatie van het secretiesignaal dat door deze cel wordt afgegeven. 
Van één van de peptiden in dit secretiesignaal, het melanoforen-
stimulerend hormoon (a-MSH), dat afkomstig is van het precursoreiwit 
proopiomelanocortine (POMO, is de functie goed beschreven. Het a-MSH 
zorgt voor verspreiding van het pigment melanine in de huidmelanoforen, 
waardoor de huid donker wordt. De melanotrope cel vormt behalve a-MSH 
verscheidene andere peptiden uit POMC, maar het was onbekend hoe deze 
peptiden er precies uitzien en of ze ook door de melanotrope cel worden 
afgegeven. Een belangrijke groep van POMC eindproducten wordt gevormd 
door de endorfinen, die aanwezig zijn in de C-terminus van POMC. In 
hoofdstuk 2 wordt behandeld hoe deze producten gekarakteriseerd en volledig 
geïdentificeerd zijn door middel van 'fast-atom bombardment' 
massaspectrometrie. Dit onderzoek heeft geleid tot de ontdekking van een tot 
nu toe onbekend geacetyleerd endorfine, het a,N-acetyl-ß-endorfine[l-8]. 
Een belangrijke eigenschap van de melanotrope cellen is de acetylering 
van a-MSH, waardoor het effect van a-MSH op de huidmelanoforen meer 
dan 10 keer wordt versterkt. In hoofdstuk 3 is onderzoek naar de acetylering 
van zowel a-MSH als van de endorfinen beschreven. Eén van de resultaten is 
het verschil in het moment waarop deze peptiden geacetyleerd worden. De 
acetylering van endorfinen gebeurt snel en is al afgerond voordat de peptiden 
afgegeven worden, maar de acetylering van a-MSH vindt pas plaats op het 
moment van afgifte. Dit wijst op de aanwezigheid van meer dan één 
acetyleringsenzym. Voorts zijn duidelijke verschillen gevonden in de 
aanwezigheid van endorfinen en a-MSH in het secretiesignaal van melanotrope 
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cellen van dieren die aangepast waren aan respectievelijk een witte en een 
zwarte achtergrond. 
Hoofdstuk 4 behandelt de opheldering van de enzymatische 'processing' 
van het N-terminale gedeelte van POMC en de karakterisatie van de 
processingsproducten. Het blijkt dat deze processing onvolledig is. Dit 
resulteert in de aanwezigheid van grote, N-terminale peptiden naast γ-MSH-
peptiden. De γ-MSH-peptiden, die maar een klein gedeelte uit lijken te maken 
van het secretiesignaal, zijn geïdentificeerd door middel van 'electrospray' 
massaspectrometrie. In dit hoofdstuk is een processingsschema van het 
complete POMC gepresenteerd. 
Het schema in hoofdstuk 4 kan verder worden uitgebreid met de 
resul ta ten uit hoofdstuk 5, waar, door midde l van een andere 
massaspectrometr ische techniek (MALDI-MS), POMC pept iden zijn 
geanalyseerd uit een enkele melanotrope cel. Op deze manier konden op basis 
van het molecuulgewicht verschillende РОМСд and POMCB peptiden van 
elkaar worden onderscheiden en is een aantal nieuwe POMC peptiden 
geïdentificeerd. 
De eerste vijf hoofdstukken tonen het belang van nieuwe detectie 
technieken voor de karakterisering van peptiden en peptidenmengsels, vooral 
in de situaties waarin conventionele aminozuursequentie-bepalingsmethoden 
tekort schieten (bv. door de aanwezigheid van een acetyl- of een suikergroep). 
De laatste twee hoofdstukken behandelen de regulatie van de afgifte 
van de hierboven genoemde POMC peptiden. In hoofdstuk 6 is de afgifte van 
radioactief gemerkte POMC peptiden gevolgd en is de aanwezigheid van twee 
differentieel gereguleerde afgifteroutes aangetoond. Beide routes bleken 
gevoelig voor remming door dopamine, maar alleen de route met rijpe peptiden 
is gevoelig voor stimulatie door sauvagine (Hoofdstuk 6). 
Tenslotte is in hoofdstuk 7 onderzoek beschreven naar de rol van de 
neurotransmitter acetylcholine. Evenals het peptide sauvagine blijkt deze stof 
de afgifte van POMC-peptiden te stimuleren. Acetylcholine heeft een 
concentratie-afhankelijk s t imulerend effect op de zogenaamde 
calciumoscillaties in de melanotrope cel. Deze vinding bevestigt het idee dat 
de intracellulaire calciumconcentratie de drijvende kracht vormt achter de 
secretie van POMC-peptiden. In farmacologische studies is aangetoond dat de 
acetylcholinereceptor een Mi-type muscarine receptor is, en met behulp van 
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immunocytochemie is deze receptor gelokaliseerd op de melanotrope cel. 
Opmerkelijk is dat de melanotrope cel zelf optreedt als producent van 
acetylcholine. Deze resultaten suggereren dat de melanotrope cel onder 
autoexcitatoire controle staat van acetylcholine. 
De vindingen zoals die in dit proefschrift beschreven staan geven een 
beter inzicht in (2) de regulatie van de hormoonafgifte door neurale factoren 
en (2) de complexiteit van het afgiftesignaal van de melanotrope cel van Xenopus 
laevis. Ze zullen hopelijk bijdragen tot een beter begrip van neuroendocriene 
communicatie in het algemeen. 
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